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EXECUTIVE SUMMARY 
 
Introduction 
 
The Scottish Crime and Justice Survey (SCJS) is a large-scale survey measuring 
people‟s experience and perceptions of crime in Scotland. The survey is conducted 
biennially and based on a representative sample of adults (aged 16 and over), living 
in private households in Scotland. The aims of the SCJS are to: 
 
 Provide a valid and reliable measure of people‟s experiences of crime, 
including services provided to victims of crime. 
 Examine trends in the number and nature of crimes in Scotland over time. 
 Examine the varying risk of crime for different groups of adults in the 
population. 
 Collect information about people‟s experiences of, and attitudes to a range of 
crime and justice related issues. 
 
The main survey is based on 12,045 face-to-face interviews which are conducted in 
private households. Respondents are also asked to answer a separate self-
completion module on more confidential and sensitive issues, including drug taking, 
partner abuse, sexual victimization and stalking. The self-completion section of the 
SCJS 20102/13 questionnaire was completed by 10,235 respondents, which 
represents 85% of all respondents.  
This report specifically examines the findings from the self-completion questionnaire 
on illicit drug use in Scotland1.  The 2012/13 survey is the fourth year of the SCJS, 
with the first being conducted in 2008/09, although crime and victimisation surveys 
have been carried out in Scotland since the early 1980s. 
The report has two substantive chapters considering: the prevalence of illicit drug 
use in Scotland exploring trends in self-reported drug use and the experiences of 
those who reported drug use Scotland.   The report examines self-reported illicit drug 
use by adults aged over 16 using three time periods: in the last month, in the last 
year and ever.  
  
                                               
1 The overwhelming majority of drugs included are illicit, but also includes glue, solvents, „new‟ drugs 
(New Psychoactive Substances) and prescribed drugs used illicitly.  The findings in this report reflect 
what respondents perceived the drug to be and therefore not necessarily the actual drug used (for 
example some people may report taking ecstasy when it is possible they may have taken a „new‟ 
drug). 
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Key Findings 
Prevalence of illicit drug use in Scotland 
 In the SCJS 2012/13, 6.2% of adults reported having used one or more illicit 
drugs in the last year, in comparison to 7.6% of adults in the SCJS 2008/09. 
This represents a statistically significant decrease between 2008/09 and 
2012/13. 
 In the SCJS 2012/13, 23% of adults reported having used one or more illicit 
drugs at some point in their lives, in comparison to 25.6% of adults in the 
SCJS 2008/09. This represents a statistically significant decrease between 
2008/09 and 2012/13.  
 Looking at drug use by legal classification, the SCJS 2012/13 found that 2.6% 
of adults reported use of Class A drugs; 5.3% of adults reported use of Class 
B drugs; and 1% of adults reported use of Class C drugs in the last year. 
 There has been a statistically significant decrease in reported use of Class A 
and Class B drugs (-0.8 and -1.1 percentage points respectively) in the last 
year between 2008/09 and 2012/13. 
 Cannabis is the most common drug used with 5.1% of adults reporting use in 
the last year.  
 Cocaine use in the last year has decreased significantly from 2.7% in 2008/09 
to 1.7% in 2012/13. 
 There has been a statistically significant decrease in adults reporting use of 
cannabis (-1.1 percentage points), cocaine (-1.0 percentage points), ecstasy 
(-0.5 percentage points) and tranquilisers (-0.4 percentage points) in the last 
year between 2008/09 and 2012/13. 
 There has been a statistically significant decrease in those reporting that 
someone has offered to give or sell them at least one type of illicit drug in the 
last year with around one in ten adults (10.6%) reporting being offered at least 
one type of illicit drug in the last year in comparison to 13.7% of adults in 
2008/09. 
 Illicit drug use is associated with demographic, socio-economic, and 
geographic factors. In the SCJS 2012/13, 16.4% of adults aged 16-24 
reported using any illicit drugs in the last year. This represents a statistically 
significant 7.1 percentage point decrease from the SCJS 2008/09. 
 0.5% of adults reported having taken any of the „new drugs‟ in the last year. 
The experiences of adults reporting illicit drug use in Scotland  
 Cannabis is the most frequently used drug in the last month with 75.9% of 
adults who had used illicit drugs in the last month reporting the use of 
cannabis. 
 Of all adults who had used any illicit drug in the last month, around a third 
(34.1%) reported using their most frequently used drug once or twice in the 
last month; three out of ten (30.2%) reported using their most frequently used 
drug on almost a daily basis; and around a quarter (26.4%) reported using 
their most frequently used drug between one to six days a week.  
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 Around a quarter of adults (23.2%) who had used drugs in the last month said 
that they felt dependent on the drug they used most often. 
 The majority of adults said that it was very easy (45.4%) or fairly easy (39%) 
to get hold of the drug used most often in the last month. 
 Over half of adults (54.1%) who had taken more than one illicit drug in the last 
year, said that they had taken different drugs at the same time in the last year. 
 Of all adults who had taken any illicit drugs in the last year, around three out 
of five adults (64.2%) reported that they had consumed alcohol at the same 
time as taking drugs in the last year. 
 The most common age for first trying drugs was the late teens (16-19). 
 Of all adults who had taken any illicit drugs at some point in their lives, the 
majority reported that their first drug used was cannabis (79.7%). 
 The majority of adults (92.2%) who reported taking illicit drugs at some point 
in their lives did so by smoking, sniffing or inhaling them. Around two in five 
(41.3%) also reported that had tried to swallow, eat or drink drugs. 
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1 INTRODUCTION 
 
1.1 Introduction 
The Scottish Crime and Justice Survey (SCJS) is a large-scale survey measuring 
adults‟ experience and perceptions of crime in Scotland.  The main aims of the SCJS 
are to: 
 Examine trends in the number and nature of crimes in Scotland over time, 
providing a complementary measure of crime compared with police recorded 
crime statistics; 
 Examine the varying risk of crime for different groups of adults in the 
population; 
 Provide a valid and reliable measure of adults' experience of crime, including 
services provided to victims of crime; 
 Collect information about adults' experiences of, and attitudes to, a range of 
crime and justice related issues. 
The main survey is based on face-to-face interviews which were conducted in 
respondents‟ homes between April 2012 and March 2013.  In 2012/13, 12,035 
respondents completed the main survey.  Respondents were also asked to answer a 
separate self-completion module on more confidential and sensitive issues, including 
drug taking, partner abuse, sexual victimization and stalking.  This self-completion 
section was completed by 10,235 respondents (85% of all respondents).   
This report presents the key findings about illicit drug use collected through the self-
completion section of the survey. A Technical Report and User Guide are also 
available.2  The SCJS is the only source of information on self-reported illicit drug 
use among the general adult population of Scotland as a whole.3   
The report has two substantive chapters considering: the prevalence of illicit drug 
use in Scotland exploring trends in self-reported drug use and experiences of those 
who reported drug use Scotland.   The report examines self-reported illicit drug use 
by adults aged over 16 using three time periods: in the last month, in the last year 
and ever.  
 
 
 
 
                                               
2 The SCJS 2012/13 Main Findings Report and related publications are available on the „publications‟ 
section of the Scottish Government website: http://www.scotland.gov.uk/Publications/2014/03/9823. 
The SCJS also has a dedicated website: http://www.scotland.gov.uk/Topics/Statistics/Browse/Crime-
Justice/crime-and-justice-survey.    
3 The overwhelming majority of drugs included are illicit, but also includes glue, solvents, new drugs 
(New Psychoactive Substances) and prescribed drugs used illicitly. While drugs such as valium and 
temazepan were included in the list of drugs asked about in the questionnaire, the question wording 
emphasised that only details of drugs not given on prescription were of interest. 
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1.2 Drug Use  
The main aim of the self-completion illicit drug use questionnaire was to establish 
whether adults aged 16 or over reported illicit drug use either at some point in their 
lives, in the last year and in the last month. Sixteen drugs were included in the 
2008/9 and 2009/10 surveys with five „new‟ drugs‟4 added in the SCJS 2010/11 
(BZP, GBL, khat, synthetic cannabinoids and mephedrone) and one new drug added 
in 2012/13 (salvia divinorum). In the SCJS 2012/13, respondents were asked 
whether they had used 18 illicit drugs or groups of illicit drugs. The list of drugs 
included a fictitious drug „semeron‟ and eleven respondents who said they had taken 
this drug were removed from the analysis. The list of drugs also included six new 
drugs. Respondents were asked whether they had used a group of five new drugs 
(BZP, GBL, Synthetic Cannabinoids, Khat or Salvia Divinorum) and separately 
whether they had used the new drug mephedrone. Those who had used any types of 
drugs were then asked a series of follow-up questions. Further details of the 
questionnaire content can be found in Annex 2 (section A.2.2). 
 
1.3 Methodology 
The SCJS 2012/13 fieldwork was conducted between April 2012 and March 2013. 
The design of the 2012/13 SCJS remains broadly similar to the 2008/09 to 2010/11 
survey designs. A change to design was made for the SCJS 2012/13 which saw the 
survey move to a single stage unclustered sample design. The SCJS used a random 
probability sample method and was designed to be representative of the population 
of households in Scotland and adults aged 16 or over living in those households. 
The SCJS was sampled from private residential addresses in Scotland using the 
Royal Mail Postcode Address File (PAF). One adult aged 16 years or over per 
household was then randomly selected for interview. As the survey only included 
private residential addresses, it is acknowledged that it can underrepresent key 
groups who are likely to use illicit drugs (section 1.4.2). 
Questions on illicit drug use were included in the self-completion section of the 
questionnaire, which was undertaken at the end of the main SCJS interview. 
Respondents were handed the interviewer‟s tablet computer and guided by the 
interviewer through a series of practice questions which explained how to use the 
computer. Where respondents were unable or unwilling to use the tablet computer 
themselves, interviewers administered the interview, showing the respondent the 
screen and helping them to input their answers. Participation was voluntary, with 
10,235 (85%) of the 12,050 respondents to the main survey completing the self-
completion questionnaire. Non-response was higher among adults aged 60 and over 
(see Annex 2 – section A.2.5). 
A more detailed explanation of the methodology for the survey can be found in the 
SCJS 2012/13 technical report.5 
                                               
4 „New drugs‟ – refers to legal or illegal psychoactive substances that were not included in the SCJS 
drugs module prior to 2010/11 and may be sold in different forms including branded products or 
mixtures as well as single „named‟ substances. 
5 The technical report is available from the Scottish Government website:  
http://www.scotland.gov.uk/Topics/Statistics/Browse/Crime-Justice/crime-and-justice-
survey/publications/SCJS2012-13-TR.  
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The data in this report has been weighted so that it is representative of the 
population (see Annex A.2.7 for information on weighting). 
1.3.1 Statistical significance 
A range of tests for statistical significance in the report were carried out using the 
Pearson chi-square test in SPSS. All significant associations in the report were found 
to be statistically significant at the p < 0.001 level.  Tests for strength of association 
were carried out using Phi and Cramer‟s V tests in SPSS. 
 
The assessments of statistical change over time which are presented in this report 
use estimated confidence intervals around survey results rounded to one decimal 
place to examine whether the change is statistically significant. The estimated 
confidence intervals used in these tests use generic SCJS design factors of 1.3 for 
2012-13 and 1.5 for earlier surveys. More detail on the derivation of these design 
factors is available in Annex 4 of the Scottish Crime and Justice Survey 2012/13: 
Main Findings report. Statistically significant changes are highlighted in bold in tables 
in this report. Changes stated between previous sweeps of the SCJS and the SCJS 
2012/13 represent a decrease or increase in percentage points. 
 
1.4 Data Strengths and Limitations 
 
1.4.1 Data strengths 
The SCJS Drug Use survey is the best source of data available on prevalence of 
illicit drug use in the general adult population of Scotland.  It is also the primary data 
source available on the prevalence of cocaine use in Scotland.   
 
1.4.2  Data limitations 
Under-reporting and under-representation of illicit drug use is a main concern of this 
survey. It is likely that there will be an under-representation of some groups who take 
drugs. In part, this will be due to the fact that some people who use drugs may live in 
accommodation not covered by a survey of private households (such as the SCJS) 
including, for example, hostels, prisons and student halls of residence. The survey is 
likely to under-represent those with the most problematic or chaotic drug use, some 
of whom may live in accommodation previously described and some of whom may 
live in private households covered by the survey, yet they may be rarely be at home 
or be unable to take part in an interview due to the chaotic nature of their lives. 
Despite using Computer Assisted Self-completion Interviewing (CASI) for this 
module, it is likely there will be a certain amount of underreporting of illicit drug use 
among survey respondents. Illicit drug use is an illegal activity and as such some 
individuals may have felt uncomfortable reporting that they have taken illicit drugs, 
despite reassurances about confidentiality and anonymity. 
Questions cover past use over varying periods (ever, in the last year and in the last 
month) and it is possible that some respondents may simply forget occasional uses 
of a certain drug, particularly if they last took it a long time ago. While under-
reporting of drug use on surveys such as the SCJS is almost certain, it should be 
noted that the issues discussed above are unlikely to apply equally across all types 
of drugs. While a survey such as the SCJS is likely to provide an insight into the 
more commonly used drugs, in particular cannabis, it may be less effective in 
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providing information for some of the Class A drugs such as opiates or crack 
cocaine, where a sizeable number of those using these drugs may be concentrated 
in small sub-groups of the population not covered by the survey (Smith and Flatley, 
2011). 
It is also recognised that some people may report taking particular drugs when they 
have not actually done so. Respondents were therefore asked whether they had 
ever taken a fictitious drug „semeron‟. Eleven respondents reported having ever 
taken semeron and these respondents have been excluded from the analysis in this 
report (making the overall sample 10,224 respondents).  
 
1.5 Classification of drugs 
The Misuse of Drugs Act 1971 classifies illegal drugs into three categories (Class A, 
B and C) according to the harm they cause. The 17 drugs or groups of drugs that 
respondents were asked about and their classification under the Act are: 
 Class A, including cocaine, crack, crystal meth, ecstasy, LSD, magic 
mushrooms, heroin, methadone and amphetamines (if prepared for 
injection);6 
 Class B, including amphetamines (in powdered form) and cannabis; 
 Class C, including ketamine, temazepam, valium and anabolic steroids; 
 Not classified, including poppers and glues, solvents, gas or aerosols.  
 ‘New’ drugs, including mephedrone and BZP, GBL, Synthetic Cannabinoids, 
Khat and Salvia Divinorum. 
In addition to reporting by Class, a number of other composite drug groups are 
reported. These composite groups, and the individual drugs that they include, are: 
 Opiates, including heroin and the illicit / non-prescribed used of methadone; 
 Stimulant drugs, including cocaine, crack, crystal meth, ecstasy, 
amphetamines and poppers; 
 Psychedelics, including LSD, magic mushrooms and ketamine; 
 Downers / tranquilisers, including temazepam and valium. 
The groups include illicit drugs across the legal classifications and reflect the drugs‟ 
shared properties, effects and characteristics, providing an additional measure to the 
class-based categorisation. For example, stimulant drugs may be used 
interchangeably by the same people at similar times and in similar settings. Drugs 
                                               
6 The SCJS does not collect details of whether amphetamine was prepared for injection or in 
powdered form. As injection as a method of taking drugs ever reported in the SCJS 2012/13 was 
relatively rare, all self-reported amphetamine use is included in Class B in the analysis that follows. 
Percentage figures in the report are displayed to one decimal place. However, it 
should be noted that there is in fact a range of uncertainty around all survey 
estimates and that the statistical testing conducted to assess change and differences 
between survey results (as outlined in section 1.3.1) are based on confidence 
intervals around survey estimates rounded to one decimal. 
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not included in the composite groups such as cannabis, anabolic steroids and glues, 
solvents, gas or aerosols, are included separately in appropriate figures where 
sufficient data are available to do this. 
In addition to the 16 drugs included in the 2008/9 and 2009/10 surveys and the 5  
new drugs included in the SCJS 2010/11 (mephedrone, BZP, GBL, synthetic 
cannabinoids and khat), the new drug salvia divinorum was added to the SCJS 
2012/13. In the SCJS 2012/13 questionnaire, respondents were asked whether they 
had taken any of five drugs from a group of new drugs (BZP, GBL, synthetic 
cannabinoids, khat or salvia divinorum) and separately whether they had taken the 
new drug mephedrone. These new drugs have been excluded from the overall 
analysis presented in the report (therefore all percentages exclude new drugs) and 
the trend analysis to ensure consistency with previous sweeps of the SCJS. Section 
2.7 of the report specifically examines use of new drugs. It should be recognised that 
as these drugs were previously (or currently) legal, for respondents reporting use of 
them ever, this does not necessarily represent an illicit activity. 
1.6 A note on reference periods 
In the survey, respondents were asked about their history of drug use over three 
different time periods. These, with their respective strengths and limitations, are: 
 Self-reported use ever: whether respondents had used specific drugs at some 
point in their lives, providing useful contextual information when, for example, 
examining general attitudes to drugs. However, this is not a useful indicator of 
current drug use or recent trends since it can include people who have used a 
drug once, perhaps a long time ago; 
 Use in the last year: whether respondents had used specific drugs in the year 
prior to interview. This time frame is generally regarded as the most stable 
measure of current drug use, especially when analysing trends over time;7 
 Use in the last month: whether respondents had used specific drugs in the 
month prior to interview. This time frame provides the most up-to date 
information on usage. It is particularly focused on when considering drug 
dependency. However, since it is a relatively short time period it is more prone 
to variation, for example, it may miss people who use drugs regularly but who 
have not done so within the last month. 
 
1.7 Comparing the SCJS 2012/13 with the CSEW 2012/13 
Due to the fact that the Crime Survey for England and Wales (CSEW) 2012/13 self-
completion questionnaire was asked of respondents aged between 16 and 59 years 
while the SCJS was asked of respondents of 16 years and over (i.e. including those 
aged 60 or over), care should be taken when comparing SCJS and CSEW data. In 
this report, where comparisons are made with the CSEW 2012/13, the SCJS 
2012/13 data have been filtered to exclude those aged 60 years and over. With 
regards to the self-completion module on drugs, the methodology and time frame of 
the CSEW 2012/13 were largely similar to the SCJS 2012/13 although there were 
                                               
7 As interviewing for the SCJS 2012/13 was continuous over the course of 12 months from April 2012 
to the end of March 2013, the reported measure of „in the last year‟ covers a 23 month period which 
varies according to the date of the interview. More information on the survey „reference period‟ is 
available in the Technical Report: http://www.scotland.gov.uk/Topics/Statistics/Browse/Crime-
Justice/crime-and-justice-survey/publications/SCJS2012-13-TR. 
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slight differences in the specific drugs that respondents were asked about.8 The 
prevalence figures for drug use in the last year and ever in England and Wales in 
section 2.2 of the report are based on the following drugs only: powder cocaine, 
crack cocaine, ecstasy, LSD, magic mushrooms, ketamine, heroin, methadone, 
amphetamines, methamphetamine, cannabis, tranquilisers, anabolic steroids, amyl 
nitrite and any other pills/powders/drugs smoked. 
 
1.8 Structure of the report 
The report proceeds as follows: 
Chapter 2 focuses on prevalence of illicit drug use in Scotland exploring trends in 
self-reported drug use from the SCJS 2008/09 to the SCJS 2012/13 and in 
comparison to the CSEW 2012/13 and looking at self-reported drug use by drug 
composite group, legal classification and specific drug type. This chapter also 
examines variations in self-reported drug use by demographic, socio-economic and 
geographical factors. Lastly this chapter focuses on prevalence of being offered 
drugs and the prevalence of new drugs. 
Chapter 3 focuses on the experiences of those who reported drug use. This chapter 
begins by examining self-reported drug use in the last year before going on to 
specifically focus on the experiences of adults over 16 who have used one or more 
illicit drugs in the last month looking at frequency of use; drug dependency; ease of 
obtaining drugs in the last month; and accessibility of drugs. This chapter will then 
examine experience of drug use in the last year with regards to specific drugs, 
polydrug use and joint use of alcohol and drugs. This chapter concludes by 
examining experience of drug use ever by specifically looking at the age at which 
drug was first used; the drug first used; and methods of taking drugs. 
Annex 1 contains additional data tables showing the percentage of adults who 
reported taking illicit drugs in the last month, the last year and ever.  The data are 
broken down by a range of demographic, experiential and area-related variables.   
Annex 2 provides information on the methods employed in the SCJS 2012-13, 
focussing specifically on the self-completion questionnaire.  This includes information 
on the questionnaire, disclosure of sensitive information, drugs classification, 
interview techniques, and the weighting used in the analysis of the results.    
                                               
8 More information on the drugs asked about in the CSEW 2012/13 is available in the Home Office 
(2013) Drug Misuse report and in the user guide: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225122/Drugs_Misuse2
01213.pdf 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/224235/drug-misuse-
user-guide.pdf 
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1.9 Conventions used in figures and tables 
The following conventions are used in the figures and tables for this report, including 
the annexes. 
Figures and tables 
Each figure or table has a title (1), the data source (survey and year) (2), a base 
definition and the unweighted base figures (3), and the SPSS data file variable name 
(4)9. For example: 
(1) Figure 2.3: % of adults aged 16 or over reporting use of drugs by composite 
group 
(2) SCJS 2012/13 
(3) Base: Adults aged 16 or over (10,224) 
(4) Variable Names: QEVE, Q12M, Q1M 
Unweighted base 
All SCJS percentages and rates presented in the figures and tables are based on 
weighted data (see Annex 2 for further details). However, an unweighted base is 
given below the figure, or in the table, which represents the number of respondents 
interviewed in the specified group. All unweighted bases are rounded to base 10. 
Percentages and rates where the unweighted base is less than 50 are excluded from 
the report. 
Percentages 
Row or column percentages may not add to 100 per cent due to rounding. Most 
figures / tables present cell percentages where the figures refer to the percentage of 
respondents that have the attribute being discussed. The complementary percentage 
to add to 100 per cent may not be shown. Respondents could refuse to answer any 
question they did not wish to answer. The majority of questions also had a „don‟t 
know‟ option. Percentages are often not shown for these response categories. 
A percentage may be quoted in the report text for a single category that is 
identifiable in the figures / tables only by summing two or more component 
percentages. In order to avoid rounding errors, the percentage has been 
recalculated for the single combined category and therefore may differ by one 
percentage point from the sum of the percentages derived from the figures / tables. 
Percentages in the figures in the main body of the report are displayed to one 
decimal place. 
  
                                               
9 The SPSS variable name is also often the question name. 
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2 PREVALENCE OF ILLICIT DRUG USE IN SCOTLAND 
 
2.1 Introduction  
This chapter looks at the prevalence of illicit drug use in Scotland. The chapter 
examines overall trends in drug use reported to the SCJS between 2008/09 and 
2012/13; variation in types of drug used; and socio-demographic and geographic 
variation in drug use. The chapter also examines the likelihood of being offered 
drugs and the prevalence of new drugs. 
 
Chapter Findings 
 
Self-reported drug use and trends over time 
There has been a statistically significant decrease in self-reported illicit drug use in 
the last month, in the last year and ever between the SCJS 2008/09 and the SCJS 
2012/13. The percentage of adults reporting taking one or more illicit drugs in the last 
year decreased from 7.6% to 6.2% of adults between 2008/09 and 2012/13. For 
those aged 16-59 only, reported drug use (in the last year) was similar in Scotland 
(8.5%) to England and Wales (8.2%) (Home Office, 2013). 
 
Types of drugs reported 
As in previous years, cannabis was the most commonly reported drug used by all 
adults: 5.1% of adults reported taking cannabis in the last year. The next most 
commonly reported drugs were cocaine (1.7%), ecstasy (1.3%), tranquilisers (0.8%), 
amphetamines (0.7%), and poppers (0.5%). There has been a statistically significant 
decrease in the number of adults reporting use of cannabis (-1.1 percentage points), 
cocaine (-1.0 percentage points), ecstasy (-0.5 percentage points) and tranquilisers 
(-0.4 percentage points) in the last year between 2008/09 and 2012/13. 
Looking at drug use by legal classification, the SCJS 2012/13 found that 2.6% of 
adults reported use of Class A drugs; 5.3% of adults reported use of Class B drugs; 
and 1% of adults reported use of Class C drugs in the last year. There has been a 
statistically significant decline in reported use in the last year of Class A (-0.8 
percentage points) and Class B (-1.1 percentage points) drugs between 2008/09 and 
2012/13. 
Variations in drug use 
As in previous surveys, gender and age were found to be associated with illicit drug 
use with men and those aged 16-24 reporting higher levels of drug use in the last 
year. There has been a statistically significant decrease in the number of women 
reporting illicit drug use in the last year with 3.3% of women reporting taking one or 
more illicit drugs in the last year in the SCJS 2012/13 in comparison to 4.3% of 
women in 2008/09. There has been a statistically significant reduction of 7.1 
percentage points from 23.5% to 16.4% of adults aged 16-24 reporting illicit drug use 
in the last year between 2008/09 and 2012/13. Self-reported illicit drug use was also 
significantly associated with socio-economic and geographic factors. 
 
Being offered drugs 
There has been a statistically significant decrease between 2008/09 and 2012/13 in 
those reporting that someone has offered to give or sell them at least one type of 
illicit drug in the last year with one in ten adults (10.6%) reporting that someone had 
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offered to give or sell them at least one type of illicit drug in the last year compared 
with 13.7% in 2008/09. 
 
New Drugs 
There are six new drugs included in the SCJS 2012/13 (mephedrone and a new 
drugs category comprising BZP, GBL, synthetic cannabinoids, khat and salvia 
divinorum). 0.5% of adults reported having taken any of the new drugs in the last 
year. 
 
2.2 Self-reported drug use 
The SCJS 2012/13 provides estimates of the percentage of adults aged 16 or over 
who report that they have used illicit drugs based on answers provided for three 
periods of time: in the last month; in the last year; and ever. Comparisons with the 
previous three sweeps of the SCJS help to put these findings in context and reveals 
that the percentage of adults reporting using one or more illicit drugs has been 
declining. Table 2.1 and Figure 2.1 show this decline in the number of adults 
reporting illicit drug use for all three time periods used in the survey between the 
SCJS 2008/09 and the SCJS 2012/13.10 The decline was significant comparing drug 
use reported in the 2008/09 survey with that reported in 2012/13. However, there 
were no statistically significant changes between 2010/11 and 2012/13. In the SCJS 
2012/13: 
 3.3% of adults reported having used one or more illicit drugs in the last month 
(the month prior to the survey interview). This is compared with 4.4% in 
2008/09, 4.2% in 2009/10 and 3.5% in 2010/11;  
 6.2% of adults reported having used one or more illicit drug in the last year. 
This is compared with 7.6% in 2008/09, 7.2% in 2009/10 and 6.6% in 
2010/11;  
 23% of adults reported taking one of more illicit drug at some point of their 
lives (ever). This is compared with 25.6% in 2008/09, 25.2% in 2009/10 and 
23.7% in 2010/11. 
 
Table 2.1: % reporting use of any of the listed drugs and percentage change 
from SCJS 2008/09 and SCJS 2010/11 to SCJS 2012/13 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
Percentage of all 
adults aged 16 
and over 2008/09 2009/10 2010/11 2012/13 
% change 
2008/09 – 
2012/13 
% change 
2010/11 – 
2012/13 
Ever 25.6 25.2 23.7 23.0 -2.6 -0.7 
In last year 7.6 7.2 6.6 6.2 -1.4 -0.4 
In last month 4.4 4.2 3.5 3.3 -1.1 -0.2 
Base 10,960 13,410 10,980 10,220   
Base: adults aged 16 or over  
Variable Names: QEVE_ANY, Q12M_ANY, Q1M_ANY   
Note: data highlighted in bold indicates significant differences between sweeps see section 
1.3.1 for further details 
                                               
10 Note that these figures exclude all new drugs included in each SCJS. 
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Figure 2.1: % reporting use of any of the listed drugs 
SCJS 2008/09; 2009/10; SCJS 2010/11; SCJS 2012/13 
 
Base: adults aged 16 or over (2008/09: 10,960, 2009/10: 13,410, 2010/11: 10,980, 2012/13: 
10,220) 
Variable Names: QEVE_ANY, Q12M_ANY, Q1M_ANY 
Note: Error bars represent a 95% confidence interval – see section 1.3.1 
The findings from the SCJS 2010/11 showed that self-reported illicit drug use ever, 
for 16-59 year olds, was lower in Scotland (31.4%) in comparison with the findings 
from the British Crime Survey (2010/11) for England and Wales (36.3%). A 
comparison with the Crime Survey for England and Wales (2012/13) (formerly the 
British Crime Survey), for those aged 16-59 only, shows that reported drug use (in 
the last year) was similar in Scotland (8.5%) to England and Wales (8.2%) (Home 
Office, 2013). This contrasts with self-reported drug use at some point in their lives, 
for 16-59 year olds only, which was lower in Scotland (30.3% compared to 35.9% in 
England and Wales) (Home Office, 2013). 
2.3 Self-reported drug use by composite group and by class of 
drug 
 
2.3.1 Self-reported drug use by composite group 
Figure 2.2 shows self-reported drug use by composite drug groups: stimulants, 
psychedelics, downers/tranquilisers and opiates.11 Figure 2.2 shows: 
 One in eight adults (12.3%, 535,000) reported that they had taken stimulant 
drugs at some point in their lives; 2.6% of adults (112,000) reported use of 
stimulants in the last year and 1% (44,000) in the last month.  
                                               
11 Section 1.5 provides a list of drugs by composite group. 
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 Around one in twelve adults (7.5%, 327,000) reported that they had used 
psychedelics at some point in their lives; 0.4% of adults (19,000) reported use 
of psychedelics in the last year and 0.1% (5,000) in the last month. 
 2.8% of adults (123,000) reported that they had used downers/tranquilisers at 
some point in their lives; 0.8% (33,000) of adults reported use of downers / 
tranquilisers in the last year and 0.3% (12,000) in the last month. 
 1.1% of adults (49,000) reported that they had used opiates at some point in 
their lives; 0.3% of adults (14,000) reported use of opiates in the last year and 
0.2% (11,000) in the last month.12 
There has been a statistically significant decrease in reported use of stimulant drugs 
in the last year with 2.6% of adults reporting use of stimulants in the last year in 
2012/13 in comparison to 3.9% of adults in 2008/09. There was also a statistically 
significant decrease in the number of adults reporting use of downers/tranquilisers (-
0.4 percentage points) and the use of psychedelics (-0.3 percentage points) in the 
last year between 2008/09 and 2012/13. There was no change in the number of 
adults reporting use of opiate drugs between 2008/09 and 2012/13. 
 
Figure 2.2: % reporting use of drugs by composite group 
SCJS 2012/13  
 
Base: Adults aged 16 or over (10,220) 
Variable Names: QEVE, Q12M, Q1M 
 
                                               
12 Prevalence of opiate use is particularly prone to under-estimation due to its association with 
problematic drug use. The ISD (2011) estimated that the prevalence rate of problem drug use 
(defined as problematic use of opiates including illicit and prescribed methadone use and/or the illicit 
use of benzodiazepines) was 1.7% in Scotland in 2009/10, amongst adults aged 15 and 64. 
12.3 
2.6 
1.0 
7.5 
0.4 0.1 
2.8 
0.8 0.3 
1.1 
0.3 0.2 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
Ever In last year In last month
Percentage of all adults aged 16 and over 
Stimulants Psychedelics Downers/Tranquilisers Opiates
  
 
22 
 
2.3.2 Self-reported drug use by legal classification 
Figure 2.3 shows self-reported drug use by legal classification; Class A, Class B or 
Class C13: 
 An estimated 12.9% of adults (561,000 people) reported having taken one or 
more Class A drugs at some point in their lives (ever); 2.6% (114,000) of 
adults reported that they had taken one or more Class A drugs in the last year 
and 1.1% (50,000) in the last month. 
 An estimated 21.6% of adults (936,000 people) reported having taken one or 
more Class B drugs at some point in their lives; 5.3% (230,000) of adults 
reported that they had taken one or more Class B drugs in the last year and 
2.8% (121,000) in the last month. 
 An estimated 3.8% of adults (163,000 people) reported having taken one or 
more Class C drugs at some point in their lives; 1.0% (45,000) of adults 
reported that they had taken one or more Class C drugs in the last year and 
0.4% (17,000) in the last month  
 
Figure 2.3: % of adults aged 16 or over reporting use of drugs by legal 
classification ever, in the last year and in the last month 
SCJS 2012/13 
 
Base: adults aged 16 or over (10,220) 
Variable Names: QEVE, Q12M, Q1M 
Table 2.2 reveals a statistically significant decrease in reported use of Class A and 
Class B drugs in the last year between 2008/09 and 2012/13. The decline in reported 
use of Class C drugs between 2008/09 and 2012/13 was not statistically significant. 
                                               
13 Section 1.5 provides a list of drugs by legal classification. 
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Table 2.2: Trends in % of adults reporting illicit drug use in the last year by 
legal classification from 2008/09 to 2012/13 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
Percentage of all 
adults aged 16 and 
over using drugs in 
the last year 2008/09 2009/10 2010/11 2012/13 
% change 
2008/09 – 
2012/13 
% change 
2010/11 – 
2012/13 
Class A 3.4 3.0 2.6 2.6 -0.8 - 
Class B 6.4 6.2 5.7 5.3 -1.1 -0.4 
Class C 1.3 1.3 1.2 1.0 -0.3 -0.2 
Base 10,960 13,410 10,980 10,220   
Base: adults aged 16 or over  
Variable Name: Q12M 
Note: Bold text indicates significant differences between sweeps, see section 1.3.1 for 
further details. 
 
2.4 Self-reported drug use by specific drug 
The SCJS 2012/13 findings revealed that cannabis was the most commonly reported 
drug used by all adults; this was also a key finding from the SCJS 2010/11. It was 
found that: 
 21.1% of adults reported taking cannabis at some point in their lives; 
 5.1% of adults reported taking cannabis in the last year; and 
 2.7% of adults reported taking cannabis in the last month. 
For adults who had ever taken one or more illicit drugs at some point in their lives, 
the next most commonly reported drugs after cannabis were amphetamines (7.8%), 
ecstasy (7.8%), cocaine (7.2%), poppers (5.8%) and the psychedelic drugs: magic 
mushrooms (5.4%) and LSD (5.2%).  
For adults who had taken one or more illicit drugs in the last year, the next most 
commonly reported drugs after cannabis were cocaine (1.7%), ecstasy (1.3%), 
tranquilisers (0.8%), amphetamines (0.7%), and poppers (0.5%).  
For adults who had taken one or more illicit drugs in the last month, the next most 
commonly reported drugs after cannabis were cocaine (0.6%), ecstasy (0.3%), 
tranquilisers (0.3%), amphetamines (0.2%) and heroin (0.2%).  
Figure 2.4 shows the % of adults reporting illicit drug use in the last year by specific 
drug in ranked order, from the drug most commonly used to the drug least commonly 
used. 14 
 
 
 
                                               
14 The bars for new drugs (mephredone and the new drugs category comprising BZP, GBL, SC, Khat 
and SD), which are excluded from the overall analysis in the report, are shaded light blue. 
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Figure 2.4: % reporting drug use in the last year by drug used   
SCJS 2012/13 
 
Base: adults aged 16 or over (10,220) 
Variable Name: Q12M 
Table 2.3 shows that there has been a statistically significant decrease in the 
reported use of cannabis, cocaine, ecstasy and tranquilisers in the last year between 
2008/09 and 2012/13. In 2012/13, 5.1% of adults reported using cannabis in the last 
year in comparison to 6.2% in 2008/09.  In 2012/13, 1.7% of adults reported using 
cocaine in the last year in comparison to 2.7% in 2008/09. In 2012/13, 1.3% of adults 
reported using ecstasy in the last year in comparison to 1.8% in 2008/09. In 2012/13, 
0.8% of adults reported using tranquilisers in the last year in comparison to 1.2% in 
2008/09. 
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Table 2.3: Trends in % of adults reporting use of cannabis, cocaine, ecstasy 
and tranquilisers in the last year from 2008/09 to 2012/13 
Percentage of all 
adults aged 16 and 
over using drugs in 
the last year 2008/09 2009/10 2010/11 
2012/1
3 
% 
change 
2008/09 
– 
2012/13 
% 
change 
2010/11 
– 
2012/13 
Cannabis 6.2 6.1 5.6 5.1 -1.1 -0.5 
Cocaine 2.7 2.1 1.9 1.7 -1.0 -0.2 
Ecstasy 1.8 1.9 1.4 1.3 -0.5 -0.1 
Tranquilisers 1.2 1.0 1.1 0.8 -0.4 -0.3 
Base 10,960 13,410 10,980 10,220     
 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
Base: adults aged 16 or over   
Variable Name: Q12M 
Note: Bold text indicates significant differences between sweeps, see section 1.3.1. 
 
2.5 Variations in self-reported drug use 
2.5.1 Variation by gender 
Self-reported drug use in the last month, in the last year and ever was significantly15 
associated with gender.16 Men reported higher levels of illicit drug use than women 
(see figure 2.5 in section 2.6.2): 
 29.3% of men reported taking an illicit drug at some point in their lives in 
comparison to 17.2% of women; 
 9.4% of men reported taking an illicit drug in the last year in comparison to 
3.3% of women; 
 5.3% of men reported taking an illicit drug in the last month in comparison to 
1.6% of women. 
 
Table 2.4 reveals a decrease in illicit drug use in the last year by women (-1.0 
percentage points) and by men (-1.7 percentage points) between 2008/09 and 
2012/13. The small decrease in percentage points between 2008/09 and 2012/13 for 
self-reported drug use by women in the last year was statistically significant. 
However, the decline in reported illicit drug use between 2008/09 and 2012/13 for 
men and the decline between 2010/11 and 2012/13 for both men and women were 
not statistically significant. 
 
 
                                               
15 Significant at the p < 0.001 level. 
16 The strength of the association between gender and drug use for all three time periods was not 
strong. The strongest variation in relation to gender was in self-reported drug use ever. 
  
 
26 
 
Table 2.4: Trends in reported illicit drug use in the last year by gender from 
2008/09 to 2012/13 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
Percentage of all adults aged 
16 and over 
Men 
(%) 
Men 
(Base) 
Women 
(%) 
Women 
(Base) 
2008/09 11.1 4,800 4.3 6,160 
2009/10 10.1 5,910 4.5 7,500 
2010/11 9.5 4,730 3.9 6,250 
2012/13 9.4 4,420 3.3 5,800 
% change 2008/09 to 2012/13 -1.7 
 
-1.0 
 % change 2010/11 to 2012/13 -0.1  -0.6  
Base: adults aged 16 or over  
Variable Name: Q12M 
Note: Bold text indicates significant differences between sweeps, see section 1.3.1. 
 
2.5.2 Variation by age 
Self-reported drug use in the last month, in the last year and ever was significantly17 
associated with age.18 Dividing the survey respondents into four age groups, it was 
found that the youngest age groups (16-24 years and  25-44 years) had the highest 
levels of self-reported drug use for all three time periods (see figure 2.5): 
 25-44 year olds had the highest reported level of illicit drug use at some point 
in their lives (39%) in comparison to 31.2% of 16-24 year olds; 18.9% of 45-59 
year olds; and 4.3% of adults aged 60 or over; 
 16.4% of 16-24 year olds reported taking an illicit drug in the last year 
decreasing to 9.7% of 25-44 year olds; 2.5% of 45-59 year olds; and 0.3% of 
those aged over 60; 
 8.4% of 16-24 year olds reported taking an illicit drug in the last month 
decreasing to 5% of 25-44 year olds; 1.7% of 45-59 year olds and 0.3% of 
those aged over 60. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
17 Significant at the p < 0.001 level. 
18 A strong relationship was found between age and self-reported drug user ever. 
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Figure 2.5: Variation in drug use ever, in the last year and in the last month by 
gender and age 
 SCJS 2012/13 
 
Base: adults aged 16 or over with age and gender group (16-24 860; 25-44 3,100; 45-59 
2,730; 60+ 3,540; Male; 4,420 Female; 5,800) 
Variable Names: QEVE_ANY, Q12M_ANY, Q1M_ANY 
Figure 2.6 shows a statistically significant decrease in reported use of illicit drugs in 
the last year by 16-24 year olds between 2008/09 and 2012/13.  
 16.4% of 16-24 year olds reported taking any illicit drug in the last year in the 
SCJS 2012/13 signalling a downward trend from the previous SCJS surveys 
where 23.5% of 16-24 year olds in 2008/09, 20.2% of 16-24 year olds in 
2009/10 and 20.3% of 16-24 year olds in 2010/11 reported taking any illicit 
drug in the last year. This represents a statistically significant reduction of 7.1 
percentage points between 2008/09 and 2012/13. 
 There were no statistically significant changes in reported drug use by other 
age groups in the last year. 
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Figure 2.6: Trends in reported drug use in the last year by age from 2008/09 to 
2012/13 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
 
Base: adults aged 16 or over19  
Variable Name: Q12M, TABAGE 
 
2.5.3 Variation by age and gender 
For both sexes, the highest level of reported illicit drug use in the last year was for 
the youngest age group with 22.1% of men and 10.5% of women aged 16-24 
reporting illicit drug use in the last year. Reported illicit drug use decreased for both 
men and women as they got older (see figure 2.7). 
 
 
 
 
 
 
 
 
 
 
                                               
19 Base: adults aged 16 and over (SCJS 2008/09: 16-24 1,000, 25-44 3,550, 45-59 2,910, 60+ 3,500;  
SCJS 2009/10: 16-24 1,160, 25-44 4,110, 45-59 3,550, 60+ 4,590; SCJS 2010/11: 16-24  970, 25-44 
3,300, 45-59 2,920, 60+ 3,790; SCJS 2012/13 16-24 860, 25-44 3,100, 45-59 2,730, 60+ 3,540. 
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Figure 2.7: Variation in drug use in the last year by gender and age 
 SCJS 2012/13 
 
Base: adults aged 16 or over in each age group by gender (All adults (Total) 10,220; Men 
4,420; Women 5,800) 
Variable Name: Q12M 
 
2.5.4 Variation in drug use by other factors 
Self-reported drug use in the last year was significantly20 associated with socio-
economic classification21; housing tenure22; urban/rural classification; victim status23 
and area deprivation. The strongest differences in self-reported drug use in the last 
year were in relation to housing tenure24 (see figure 2.8).  
 Those classified in the routine and manual socio-economic group were more 
likely to report drug use in the last year (8.6% compared to 6.2% in the 
intermediate occupation group and 5.3% in the managerial and professional 
group). Of those classed as „never worked and long-term unemployed‟ - 4.7% 
reported illicit drug use in the last year. 
 Those who own their own property were less likely to report using illicit drugs 
in the last year (3.5% compared to 12.2% who privately rent and 10.5% who 
rent socially). 
                                               
20 Significant at the p < 0.001 level. 
21 Details of the National Statistics socio-economic categories can be found on the ONS website - 
http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-
classifications/soc2010/soc2010-volume-3-ns-sec--rebased-on-soc2010--user-manual/index.html 
22 Note: Not all respondents to the questionnaire classified themselves in any of the four NS-SEC 
categories or in the three housing tenure categories and therefore the sub-categories do not add up to 
the overall base sample for NS-SEC group or Housing Tenure. 
23 A victim is defined as a respondent who reported crimes or offences in the main questionnaire 
(excludes sexual offences and threats) which are within the scope of the survey, took place in 
Scotland and occurred within the reference period.  
24 Strength of association measured using Phi/Cramer‟s V tests. 
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 Those who live in urban areas were more likely to report using illicit drugs in 
the last year (7% compared to 2.7% of those living in rural areas). 
 Victims of crime were more likely to report using illicit drugs in the last year 
(10.8% compared to 5.2% of non-victims). 
 Those classified as living in the 15% most deprived areas based on the 
Scottish Index of Multiple Deprivation25 were more likely to report using illicit 
drugs in the last year than those not living in the 15% most deprived areas 
(8.8% compared to 5.7%).  
 
Figure 2.8: % reporting illicit drug use in the last year by socio-economic 
group, housing tenure, urban/rural location, victim status and SIMD Index 
 SCJS 2012/13 
 
Base: adults aged 16 or over in group26  
Variables Names: Q12M_ANY; TABNSSEC; TABTEN; TABURBRUR; VICFLAG3; 
SIMD_TOP 
 
2.6 Being offered drugs in the last year 
The SCJS 2012/13 estimated that around one in ten adults (10.6%) reported that 
someone had offered to give or sell them at least one type of illicit drug in the last 
year. Comparing this to previous sweeps of the SCJS reveals a statistically 
                                               
25 Details of the Scottish Index of Multiple Deprivation can be found on the Scottish Government 
website - http://www.scotland.gov.uk/Topics/Statistics/SIMD 
26 Base sizes are for all socio-economic groups (Management & Professional 1,990; Intermediate 
1,460, Routine and Manual, 2,200, Never Worked & Long Term Unemployed, 3,770), housing tenure 
groups (Owner occupier 6,510, Social rented 2,310, Private Rented 1,230), urban/rural location 
(Urban 8,110, Rural 2,110), victim status (Non-Victim 8620, Victim 1,600), and SIMD index (15% most 
1,470, All other areas, 8,620). 
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significant decline in those reporting that someone had offered to give or sell them at 
least one type of illicit drug in the last year with 13.7% of adults reporting being 
offered drugs in the SCJS 2008/09 and 11.6% in the SCJS 2010/11 (a drop of 3.1 
percentage points).  
Compared with previous sweeps of the SCJS, the SCJS 2012/13 found (see figure 
2.10): 
 6.6% of adults reported being offered at least one stimulant drug in the last 
year signalling a statistically significant decline from the SCJS 2008/09 where 
9.8% of adults reported being offered stimulant drugs (a fall of 3.2 percentage 
points); 
 1.3% of adults reported being offered tranquilisers/downers in the last year 
signalling a statistically significant decline in comparison to the SCJS 2008/09 
(-1.5) and the SCJS 2010/11 (-1.0). 
 
Figure 2.10 % being offered an illicit drug by composite group in the last year 
SCJS 2012/13 compared with previous sweeps 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
 
Base: adults aged 16 or over (2008/09 10,960, 2009/10: 13,410, 2010/11: 10,980, 2012/13: 
10,220) 
Variables Name: QOF2 
Drugs legally classified as Class B were the most commonly reported to have been 
offered in the last year (8.6%). For all three types of drug class, comparisons with the 
SCJS 2008/09 reveal a statistically significant decline in adults reporting they have 
been offered drugs (Class A -2.5; Class B -2.4; Class C -1.1). There was also a 
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statistically significant decline in adults reporting being offered Class C drugs 
between 2010/11 and 2012/13 (-0.7). This is part of an overall declining trend over 
the last 4 sweeps of the SCJS (figure 2.11) 
Figure 2.11 % being offered an illicit drug by legal classification in the last year 
SCJS 2012/13 compared with previous sweeps 
SCJS 2008/09; SCJS 2009/10; SCJS 2010/11; SCJS 2012/13 
 
Base: adults aged 16 or over (2008/09 10,960, 2009/10: 13,410, 2010/11: 10,980, 2012/13: 
10,220) 
Variables Name: QOF2 
 
Figure 2.12 shows the percentage of adults aged 16 or over who reported that 
someone had offered to give or sell them at least one type of illicit drug in the last 
year by composite drug group; legal classification of drugs; and the most commonly 
offered drugs (cannabis, cocaine and ecstasy). 
Just less than one in ten adults (8.3%) reported being offered cannabis in the last 
year, 4.7% reported being offered cocaine and 4% reported being offered ecstasy. 
Comparing these figures with previous sweeps of the SCJS also revealed a 
statistically significant decrease between 2008/09 and 2012/13 (cannabis -2.0; 
cocaine -2.3; ecstasy -2.3). 
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Figure 2.12: % of adults aged 16 or over being offered drugs in the last year by 
type of drug  
 SCJS 2012/13  
 
Base: Adults aged 16 or over (10,220) 
Variable Name: QOF2  
 
2.6.1 Variation in being offered drugs by gender  
Bases: Men - 4,420; Women - 5,804 
Men were more than twice as likely as women to report being offered an illicit drug in 
the last year (15.5% in comparison to 6.2%). Men were also more likely than women 
to report being offered each of the specific drugs. 
2.6.2 Variation in being offered drugs by age  
Bases: 16-24 - 859; 25-44 – 3,103; 45-49 2,727; 60+ 3,535 
Over a quarter of 16-24 year olds (29.5%) reported being offered an illicit drug in the 
last year. In comparison, 15.5% of 25-44 year olds, 4.6% of 45-59 year olds and 
0.9% of those aged over 60 reported being offered an illicit drug in the last year. 
2.6.3 Variation in being offered drugs by other factors 
Bases: Victim 1,602 Non-Victim 8,522; Manage & Prof 1,987; Intermediate 1,456, Routine & 
Manual 2,204, Not working and Long term Unemployed 3,768; Urban 8,114, Rural 2,110; 
Owner Occupier 6,513, Social rented 2,306, Private Rented 1,229; 15% most deprived areas 
1,472, Remaining areas of Scotland 8,752. 
Being offered drugs in the last year varied by socio-economic group, housing tenure, 
urban/rural classification, victim status and area deprivation. 
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 Those classified as working in the routine and manual occupations (15.6%) 
were more likely to have been offered illicit drugs in the last year than in any 
other occupation group (in comparison to 11.5% of the managerial and 
professional occupations group, 10.6% of the intermediate occupations group 
and 6% of those classed as not working or long-term unemployed).   
 One in five of those who privately rent (20.8%) reported being offered illicit 
drugs in the last year, in comparison to 13.3% of those who socially rent and 
7.7% of those who are owner occupiers. 
 Those living in urban areas were almost twice as likely to report being offered 
illicit drugs in the last year compared to those living in rural areas (11.6% and 
6.2% respectively).  
 Victims of crime, as measured by the SCJS 2012/13, were more than twice as 
likely to have been offered illicit drugs in the last year as those who did not 
report being a victim of crime (18.5% and 9% respectively). 
 Those classified as living in the 15% most deprived areas based on the 
Scottish Index of Multiple Deprivation were more likely to report being offered 
illicit drugs in the last year than those not living in the 15% most deprived 
areas (14.3% compared to 10%).  
 
2.6.4 Variation in being offered drugs by drug use in the last year  
Around one in ten adults (10.6%) reported that someone had offered to give or sell 
them illicit drugs in the last year. Of those who had not taken drugs in the last year, 
6.4% said that they had been offered illicit drugs in the last year. This was also a 
finding in the SCJS 2010/11 and demonstrates that it is not necessarily the case that 
those reporting being offered illicit drugs would have actually used any illicit drug.  
 
2.7  New Drugs 
To ensure consistency with previous SCJS Drug Use reports, all new drugs were 
excluded from the main analysis in the rest of the report due to the small 
percentages involved.  As previously mentioned, in the SCJS 2012/13 questionnaire, 
respondents were asked whether they had taken any of five drugs from a group of 
new drugs (BZP, GBL, synthetic cannabinoids, khat or salvia divinorum) and 
separately whether they had taken the new drug mephedrone. These same drugs 
were asked about in the 2010/11 survey, with the exception of salvia divinorum 
which was added for the first time in 2012/13. 
 2.3% of adults reported taking any of the new drugs ever in the SCJS 2012/13 
in comparison to 1.8% in the SCJS 2010/11.  
 0.5% of adults reported taking any of the new drugs in the last year in the 
SCJS 2012/13 in comparison to 0.7% in the SCJS 2010/11  
 0.1% of adults reporting taking any of the new drugs in the last month in the 
SCJS 2012/13 in comparison to 0.2% in the SCJS 2010/11.  
Self-reported use of new drugs ever varied significantly27 by gender and by age. The 
strongest differences were in relation to age.28 Of the 2.3% of adults who reported 
using any new drug ever (Base: 100), 3.6% of men reported using new drugs at 
                                               
27 Significant at the p < 0.001 level. 
28 Strength of association measured using Phi/Cramer‟s V tests.  
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some point in their lives in comparison to 1.1% of women. There were also variations 
in self-reported use of new drugs ever by age with the youngest age group (16-24) 
more likely to reported use of new drugs at some point in their lives (6.1%) in 
comparison to those aged 25 to 44 (3.8%) and those aged 45 to 59 (0.7%).  
Whilst the percentage of adults ever using any of the new drugs has increased – the 
percentage of adults reporting use of the new drugs in the last year and in the last 
month has declined between 2010/11 and 2012/13. However, these changes were 
not statistically significant.  
Similarly to the findings of the SCJS 2010/11, of the new drugs, mephedrone was 
the most commonly reported drug for all three time periods: 1.4% of respondents 
reported taking mephedrone ever; 0.4% reported taking it in the last year; and 0.1% 
reported taking it in the last month. Comparing this to the SCJS 2010/11 findings, 
whilst the percentage of adults reporting the use of mephedrone ever increased from 
1.2% in 2010/11 to 1.4% in 2012/13 – the number of adults reporting use of 
mephedrone in the last year and in the last month has decreased (0.7% reported 
taking mephedrone in the last year and 0.2% reported taking mephedrone in the last 
month in the SCJS 2010/11). The decrease in the number of adults reporting use of 
mephedrone in the last year between 2010/11 and 2012/13 (-0.3) was the only 
statistically significant change amongst new drugs, however this finding should be 
treated with caution. The significance test found that the estimated change of 0.3 
percentage points is on the borderline of significance at the 95% confidence level. In 
addition, it should be noted that the test is based upon survey estimates rounded to 
one decimal place (and indeed the tests also incorporate estimated survey design 
effects). 
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3 THE EXPERIENCES OF ADULTS REPORTING DRUG USE IN 
SCOTLAND 
 
3.1 Introduction 
This chapter focuses on the experiences of those who reported drug use. As 
previously mentioned, 23% of all adults over 16 said that they had used one or more 
illicit drugs at some point in their lives. Of the adults who had used drugs at some 
point in their lives, over one quarter (27%) had used drugs in the last year. Just over 
one in twenty of all adults (6.2%) said that they had used one or more illicit drugs in 
the last year with 3.3% saying that they had used one or more illicit drug in the last 
month. This chapter begins by examining self-reported drug use in the last year 
before going on to specifically focus on the experiences of adults over 16 who have 
used one or more illicit drugs in the last month looking at frequency of use; drug 
dependency; ease of obtaining drugs in the last month; and accessibility of drugs. 
This chapter has a particular focus on drug use in the last month as this time frame 
is most useful when examining drug dependency. This chapter then examines 
experience of drug use in the last year with regards to specific drugs; polydrug use; 
and joint use of alcohol and drugs. This chapter concludes by examining experience 
of drug use ever by specifically looking at age at which drug was first used; drug first 
used; and methods of taking drugs. 
Chapter Findings 
Self-reported drug use in the last year 
Of the 6.2% of adults who reported using any illicit drugs in the last year (Base: 490), 
eight in ten (82.9%) said that they had used cannabis; 41.7% said that they had 
taken stimulants; 12.4% said that they had used downers/tranquilisers; 7% said that 
they had taken psychedelics; and 5.2% said that they had taken opiates in that time.  
 
Frequency of drug use  
Of adults who had used at least one type of illicit drug in the last month (3.3%, Base: 
270), three quarters (75.9%) reported that cannabis was their most frequently used 
drug; one in ten (10.2%) reported that cocaine was their most frequently used drug; 
and 3.1% reported that ecstasy was their most frequently used drug in the last 
month. 
Of adults who had used at least one type of illicit drug in the last month (3.3%, Base: 
270), three in ten (30.2%) had used their most frequently used drug every day or 
almost every day and over a third (34.1%) had used their most frequently used drug 
once or twice in the last month.  
Drug dependency 
Of those who reported using drugs in the last month (3.3%, Base: 270): 
 More than half (54.4%) reported that they did not feel dependent nor had tried 
to cut down and more than two fifths (44.6%) reported that they had felt 
dependent on the drug used most often in the last month or had tried to cut 
down but could not;   
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 More than a third (38.4%) said that they had tried to cut down on the drug they 
used most often in the last month and almost one quarter (23.2%) said that 
they felt dependent upon the drug used most often in the last month;  
 Almost one fifth (17%) reported that they felt dependent and tried to cut down.  
 
Ease of obtaining drugs 
The majority of adults, who had taken drugs in the last month (Base: 270), said that it 
was either very easy (45.4%) or fairly easy (39%) to get hold of the drug used most 
often in the last month. Far fewer said that it was either fairly difficult (10.9%) or very 
difficult (4.4%) to get hold of the drug used most often in the last month.  
 
Polydrug use/mixing alcohol and drugs 
Amongst those that take drugs, polydrug use is common. Of those taking more than 
one drug in the last year (Base: 206), 54.1% of adults reported that they had taken 
different drugs together at the same time. 
Of those who had taken at least one illicit drug in the last year (Base: 490), around 
three out of five adults (64.2%) reported that they had consumed alcohol at the same 
time as taking drugs. 
First drug use 
All respondents who reported having ever taken drugs (23%, Base: 2170) were 
asked what age they were when they first took drugs and what the first drug they 
used was.  
 The most common age for first trying drugs was the late teens (16-19 years) 
with over half (51.2%) of those who had reported taking drugs at some point in 
their lives first trying them at this age. 
 Around one quarter of adults (24.2%) said that they had first used drugs aged 
less than 16 and 0.8% said that they were less than 10 years old when they 
first tried drugs. 
The majority of adults reported that their first drug used was cannabis (79.7%) with 
much fewer having first tried any stimulant drug (11.9%); any psychedelic drug 
(3.7%); or tranquilisers/downers (0.8%). 
Methods of taking drugs 
Of those adults who reported having used drugs  at some point in their lives, the 
majority (92.2%) said that that they had taken them by smoking, sniffing or inhaling 
them. 
 
3.2 Self-reported drug use in the last year and in the last month 
Figure 3.1 shows the percentage of adults who had used each illicit drug in the last 
year looking only at adults who had used drugs in the last year. 
 More than eight in ten adults (82.9%) who reported using any illicit drugs in 
the last year said that they had used cannabis in that time. This represents a 
decrease in comparison to the SCJS 2010/11(83.6%) however this was not 
statistically significant. 
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 Of all adults taking drugs in the last year, 41.7% said that they had taken 
stimulants; 12.4% said that they had used downers/tranquilisers; 7% said that 
they had taken psychedelics; and 5.2% said that they had taken opiates. 
There has been a decrease in the number of adults, who had used drugs in 
the last year, reporting use of stimulants, psychedelics and 
downers/tranquilisers in the last year but an increase in those reporting opiate 
use in comparison to the SCJS 2010/11 however there were no statistically 
significant changes.  
 Of all adults taking drugs in the last year, 6.4% said that they had taken the  
new drug mephedrone and 2.7% said that they had taken any of the five 
drugs in the new drugs category.29 (For information on those taking new drugs 
out of all adults see section 2.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
29 The bars for new drugs (mephredone and the new drugs category comprising BZP, GBL, SC, Khat 
and SD), which are excluded from the overall analysis in the report, are shaded light blue. 
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Figure 3.1: % each drug type used where used one or more illicit drugs in the 
last year 
SCJS 2012/13 
 Base: Adults aged 16 or over who had used at least one illicit drug in the last year (490) 
Variable Name: Q12M 
Examining only adults who had used drugs in the last month (3.3%), figure 3.2 
shows the percentage of adults who had used each illicit drug in the last month.30   
 80.7% of adults who said that they had used any illicit drug in the last month 
reported using cannabis in that time.  
 19.3% of adults who said that they had used any illicit drug in the last month 
reported using cocaine. 
 Of all adults taking drugs in the last month, 30.2% of adults reported using 
stimulants; 8.2% of adults reported using tranquilisers/downers; 7.3% of 
adults reported using opiates; and 3.7% of adults reported using psychedelics. 
There has been a decrease in the number of adults, who had used drugs in 
the last month, reporting use of stimulants, psychedelics and 
downers/tranquilisers but an increase in those reporting opiate use in the last 
                                               
30 The bars for new drugs (mephredone and the new drugs category comprising BZP, GBL, SC, Khat 
and SD), which are excluded from the overall analysis in the report, are shaded light blue. 
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month between 2010/11 and 2012/13. However, these changes were not 
statistically significant.  
 No respondents stated that they had used crystal meth in the last month. 
 
Figure 3.2: % each drug type where used one or more illicit drugs in the last 
month  
SCJS 2012/13 
 
Base: Adults aged 16 or over who had used at least one illicit drug in the month (270) 
Variable Name: Q1M 
 
3.3 Experiences of drug use in the last month 
This section examines the single illicit drug reported as being used most often in the 
month prior to the survey interview; the frequency with which that drug was used;  
perceptions of dependency on that drug; and access to that drug.  
As previously mentioned cannabis was the most commonly reported drug used by all 
adults (5.1%) in the month before the survey interview. Looking only at those who 
reported drug use in the last month (3.3% of adults), it was found that:  
80.7 
19.3 
8.5 8.2 6.7 4.9 4.0 3.1 2.1 1.9 1.9 1.6 1.4 1.2 1.1 1.1 
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
Percentage of adults aged 16 or over who had used at least one illicit drug in the 
last month 
  
 
41 
 
 Around three quarters of adults (75.9%) reported that cannabis was their most 
frequently used drug in the last month; 
 Around one in ten adults (10.2%) reported that cocaine was their most 
frequently used drug in the last month; 
 3.1% of adults reported that ecstasy was their most frequently used drug in 
the last month; 
 Stimulants were the most used drug in the last month (16.1% of adults 
reported use of this composite group); 
 3.5% of adults reported that opiate drugs were the most used in the last 
month; 
 No adults reported crack, LSD, magic mushrooms, crystal meth, ketamine or 
glues, solvents, gas or aerosols as the drug used most often in the last month. 
 
3.3.1 Drug used more often in the last month – frequency of use 
Of the 3.3% of adults (Base: 270) who reported using drugs in the last month, 
around a third (34.1%) reported using their most frequently used drug once or twice 
in the last month. Three out of ten (30.2%) reported using their most frequently used 
drug on almost a daily basis. Around a quarter reported frequency of use of the drug 
they used most often in the last month, less than every day, but at least once a week 
or more, with just over one in ten (12.5%) reporting use of this drug 1-2 days a week, 
just under one in ten (9.5%) reporting using this drug 3-4 days each week and just 
under one in twenty (4.4%) using their most frequently used drug 5-6 days a week 
(see figure 3.3). 
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Figure 3.3: % who reported drug use in the last month by how frequently they 
have used the drug they use most often  
SCJS 2012/13   
 
Base: adults aged 16 or over who have used at least one illicit drug in the last month (270) 
Variable Name: QDROFT 
Table 3.1 shows the changes in frequency of use of the drug used most often in the 
last month between 2008/09 and 2012/13 and between 2010/11 and 2012/13. The 
table shows that there has been an increase from 20.9% to 30.2% in the number of 
adults reporting that they use their most frequently used drug every day or almost 
every day between 2008/09 and 2012/13. However, there were no statistically 
significant changes in frequency of use of the drug used most often in the last month 
between 2008/09 and 2012/13.  
Table 3.1: Trends in frequency of use of the drug used most often in the last 
month from 2008/09 to 2012/13 
Percentage of adults 
aged 16 and over who 
had used an illicit drug 
in the last month 2008/09 2009/10 2010/11 2012/13 
% 
change 
2008/09 
– 
2012/13 
% 
change 
2010/11 
– 
2012/13 
Once or twice in last 
month 38.1 34.5 37.4 34.1 -4.0 -3.3 
Every day or almost 
every day 20.9 16.5 24.3 30.2 9.3 5.9 
Base 380 440 310 270     
Base: adults aged 16 or over who had used at least one illicit drug in the last month  
Variable: QDROFT 
Once or twice 
in the last 
month 
34.1% 
Every day or 
almost every 
day 
30.2% 
1-2 days each 
week 
12.5% 
3-4 days 
each 
week 
9.5% 
5-6 days each 
week 
4.4% Not sure 
8.2% 
Don't wish to 
answer 
1.2% 
  
 
43 
 
3.3.2 Variation in drug used most often in the last month and frequency of use 
Frequency of use of the drug used most often in the last month varied by gender and 
by age. Frequency of drug use on an almost daily basis and frequency of drug use 
once or twice a month were specifically examined. 31 
Gender 
Base: Adults aged 16 and over within group: Men: 200, Women: 70 
 
 Men were more likely to report using their most frequently used drug on an 
almost daily basis in the last month (34.2%) in comparison to women (17.8%). 
 Women were more likely to report using their most frequently used drug once 
or twice in the last month (50.3%) in comparison to men (28.9%). 
Age 
Bases: Adults aged 16 and over within group: Aged: 16-24 - 70; Aged: 25-44 - 150; Aged: 
45-59 - 50; Aged 60+: # 
 
 Around three out of 10 of those aged 16 -24 (27.9%), 25-44 (29.3%) and 45-
59 (34.6%) reported using their most frequently used drug on an almost daily 
basis. 
Figure 3.4 illustrates the association between gender and frequency of drug use for 
the drug used most often in the last month. 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
31 Due to small base sizes it was not possible to test whether variations were statistically significant. 
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Figure 3.4: % frequency of drug use in the last month by gender  
SCJS 2012/13   
 
Base: adults, males and females aged 16 or over who had used at least one illicit drug in the 
last month (Adults: 270 Males: 200 Females: 70)     
Variable Names: QDROFT and QDGEN 
 
3.3.3 Drug Dependency 
Of those who had used at least one illicit drug in the last month (3.3% of adults, 
Base: 270): 
 Almost a quarter (23.2%) said that they felt dependent upon the drug they 
used most often in the last month; 
 More than a third (38.4%) said that they had tried to cut down on the drug they 
used most often in the last month whilst almost two thirds (61.6%) said that 
they had not tried to cut down on the drug used more often in the last month; 
 More than two fifths (44.6%) reported that they had felt dependent on the drug 
used most often in the last month or had tried to cut down but could not;   
 Almost one fifth (17%) reported that they felt dependent and tried to cut down;  
 More than half (54.4%) reported that they did not feel dependent nor had tried 
to cut down. 
 
Drug dependency by specific drug  
Of those who had used at least one illicit drug in the last month (Base: 270), when 
asked about the drug they used most often, one in five adults (20.1%) who used 
cannabis most often reported feeling they needed or were dependent on this drug; 
this was a much greater proportion than for other drugs: 
 20.1% said that they felt they needed/were dependent on cannabis; 
30.2 
34.2 
17.8 
4.4 
4.9 
2.8 
9.5 
10.4 
6.7 
12.5 
12.1 
13.5 
34.1 
28.9 
50.3 
8.2 
9.1 
5.4 
0% 20% 40% 60% 80% 100%
All Adults
Male
Female
Percentage of adults aged 16 and over within group who had used an illicit drug 
in the last month 
Every day or almost every day
5-6 days each week
3-4 days each week
1-2 days each week
Once or twice in the last month
Not sure
Don't wish to answer
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 2% said that they felt they needed/were dependent on any opiate drugs; 
 0.5% said they felt they needed/were dependent on any 
downers/tranquilisers; 
 0.5% said that they felt they needed/were dependent on any stimulant drugs 
 
Variation in drug dependency by gender, socio-economic group, tenure and 
area deprivation 
Of those who had used at least one illicit drug in the last month (Base: 270), when 
asked whether they felt dependent on or needed the drug they took most often, this 
response varied significantly32 by gender; socio-economic group; tenure; and area 
deprivation.   
 27.9% of men reported that they had felt dependent on the drug taken most 
often in the last month in comparison to 8.9% of women.  
 38.9% of adults in the never worked and long term unemployed socio-
economic group said that they felt they needed/were dependent on the drug 
taken most often in the last month in comparison to 22.8% of those in the 
routine and manual socio-economic group.  
 36% of adults who socially rented said that they felt they needed/were 
dependent on the drug taken most often in the last month in comparison to 
16.9% of those who privately rented and 8.1% of owner occupiers. 
 35.7% of adults living in the 15% most deprived areas in Scotland said that 
they felt they needed/were dependent on the drug taken most often in the last 
month in comparison to 19.7% of those who do not live in these areas. 
 
3.3.4 Ease of obtaining drugs in the last month 
Those who had taken drugs in the last month (Base: 270) were asked how difficult it 
was to get hold of the drug used most often in the last month. The majority said that 
this was very easy (45.4%) or fairly easy (39%) whilst far fewer said that it was either 
fairly difficult (10.9%) or very difficult (4.4%) to get hold of the drug used most often 
in the last month. There has been a decrease from 48.6% to 45.4% in the number of 
adults reporting that it was very easy to get hold of the drug use most often in the 
last month between 2008/09 and 2012/13. There has been an increase from 2.4% to 
4.4% in the number of adults reporting that getting hold of the drug used most often 
in the last month was very difficult between 2008/09 and 2012/13. However, these 
changes were not statistically significant. 
 
3.3.5 Access to drugs in the last month 
Those who had taken drugs in the last month (Base: 270) were asked who or where 
they got the drug used most often in the last month from, with specific reference to 
the last time they took the drug. 
 Over a third (36.8%) said that they had got their drug taken most often in the 
last month, the last time they used it, from „someone well known‟ to them (e.g. 
a friend, neighbour or work colleague). 
 One in five adults (21.6%) said that they got it from a known dealer. 
                                               
32 Significant at the p < 0.001 level. 
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 One in ten adults (9.8%) said they had got if from a dealer not known to them 
personally. 
 Just under one in ten (9.5%) said that they had got it from someone known to 
them only by sight or to speak to casually. 
 6.8% said that they had got it from a stranger. 
 1.8% said they had got it from a shop, 1.6% from a family member and 0.4% 
from the internet.  
 
3.4 Experiences of drug use in the last year 
This section will focus on the experience of drug use in the last year by examining 
experiences of the most commonly used drugs in the last year; polydrug use; and 
joint consumption of alcohol and drugs. 
 
3.4.1 Experiences of use of most prevalent drugs 
Cannabis 
Base: 410 
As previously mentioned, cannabis is the most used drug in the last month, last year 
and ever. All adults over 16 who had used cannabis in the last year were asked to 
describe their use of this drug. Of the 5.1% of adults who reported using cannabis in 
the last year: 
 Over a quarter of adults (25.7%) said that it was something that they had tried 
once or twice; 
 Nearly three fifths of adults (58.3%) said that it was something that they had 
used more than once or twice but would not or did not have difficulty giving it 
up if they wanted to; 
 Three out of twenty adults (14.8%) said that cannabis was something that 
they needed or were dependent on at the time of the survey or in the last 
year. 
Cocaine 
Base: 140 
After cannabis, cocaine was the next most commonly used drug in the last year 
(1.7%). Of all adults over 16 who reported using cocaine in the last year: 
 Just over two fifths of adults (42.4%) said that it was something that they had 
tried once or twice; 
 More than half of adults (55.7%) said that it was something that they had used 
more than once or twice but would not or did not have difficulty giving it up if 
they wanted to; 
 1.9% of adults said that cocaine was something that they needed or were 
dependent on at the time of the survey or in the last year. 
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Ecstasy 
Base: 100 
Ecstasy was the next most commonly used drug in the last year (1.3%). Of all 
respondents who reported using ecstasy in the last year: 
 Just over two fifths of adults (42.1%) said that it was something that they had 
tried once or twice; 
 More than half of adults (56.4%) said that it was something that they had used 
more than once or twice but would not or did not have difficulty giving it up if 
they wanted to; 
 0.3% of adults said that ecstasy was something that they needed or were 
dependent on at the time of the survey or in the last year. 
Tranquilisers 
Base: 60 
Tranquilisers were the next most commonly used drug in the last year (0.8%). Of all 
respondents who reported using tranquilisers in the last year: 
 Just less than a third of adults (31.1%) said that it was something that they 
had tried once or twice; 
 Over a half of adults (53%) said that it was something that they had used 
more than once or twice but would not or did not have difficulty giving it up if 
they wanted to; 
 Three out of twenty adults (15.9%) said that tranquilisers were something that 
they needed or were dependent on at the time of the survey or in the last 
year. 
Amphetamines 
Base: 60 
Amphetamines were the next more commonly used drug in the last year (0.7%). Of 
all respondents who reported using amphetamines in the last year: 
 A third of adults (33.6%) said that it was something that they had tried once or 
twice; 
 Around two thirds of adults (64.1%) said that it was something that they had 
used more than once or twice but would not or did not have difficulty giving it 
up if they wanted to; 
 0.5% of adults said that amphetamines were something that they needed or 
were dependent on at the time of the survey or in the last year. 
 
3.4.2 Polydrug use 
Polydrug use is the use of more than one drug at the same time, often with the 
intention of enhancing or countering the effect of another drug. Adults over 16 were 
asked whether in the last year they had taken different drugs together at the same 
time. Of all adults over 16 taking more than one drug in the last year (Base: 206), 
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54.1% of adults reported that they had taken different drugs together at the same 
time and 45.9% said that they had not. 
 
3.4.3 Alcohol and Drug Use 
Of all respondents who had taken any illicit drugs in the last year (6.2% of adults; 
Base: 490), around two thirds of adults (64.2%) reported that they had consumed 
alcohol at the same time as taking drugs and just over a third of adults (35.8%) said 
that they had not. 
Self-reported consumption of alcohol at the same time as taking drugs in the last 
year was significantly33 associated with gender, age, socio-economic classification, 
housing tenure and area deprivation. The strongest differences34 were in relation to 
socio-economic group and housing tenure (see figure 3.5). 
 Men were more likely to report consuming alcohol at the same time as taking 
drugs than women (65.9% and 59.8% respectively).  
 Those aged 16-24 were more likely to report consuming alcohol at the same 
time as taking drugs in the last year (67.6%) in comparison to 64.4% of those 
aged 25-44, 52.2% of those aged 45-59 and 53.7% of those over 60. 
 Those in the managerial/professional socio-economic group were more likely 
to report consuming alcohol at the same time as taking drugs in the last year 
(72.6%) in comparison to 69.4% of adults in the intermediate group; 68.7% of 
adults in the routine and manual socio-economic group; and 50.4% of adults 
in the not working and long-term unemployed group. 
 Owner occupiers were more likely to report consuming alcohol at the same 
time as taking drugs in the last year (72.8%) in comparison to 53.8% of those 
who socially rent and 65.0% who privately rent.  
 Those not living in the SIMD 15% most deprived areas in Scotland were more 
likely to report consuming alcohol at the same time as taking drugs in the last 
year (66.9%) in comparison to 54.2% of adults living in the SIMD 15% most 
deprived areas.  
The SCJS 2012/13 findings specifically on joint consumption of alcohol and drugs 
amongst adults who self-reported taking any illicit drugs in the last year shows a 
different pattern than findings on drug use only in the last year when looking at socio-
economic group, tenure and area deprivation. Those in the managerial/professional 
socio-economic group, those who are owner-occupiers and those not living in the 
15% most deprived areas of Scotland were the most likely to report that they had 
consumed alcohol and drugs at the same time from all those who have taken drugs 
in the last year. These are the three groups which are the least likely to report any 
illicit drug use in the last year based on all respondents (see figure 2.8).   
 
 
 
                                               
33 Significant at the p < 0.001 level. 
34 Strength of association measured using Phi/Cramer‟s V tests. 
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Figure 3.5: % reporting consumption of alcohol at the same time as using 
drugs by gender, age, socio-economic group, housing tenure and SIMD Index   
SCJS 2012/13      
 
Base: adults aged 16 or over who have reported use of one or more illicit drugs in the last 
year within group) 
35
     
Variables Names: Q12MALC; QDGEN; TABAGE; TABN SSEC; TABTEN; SIMD_TOP 
 
3.5 Experiences of adults who have taken drugs at some point in 
their lives 
Having examined experiences of drug use in the last month and in the last year – 
this section will explore experiences of drug use of all adults who reported taking 
illicit drugs at some point in their lives (Base: 2170) through examining: age at which 
drugs used were first taken; first drug ever used; and methods of taking drugs. 
 
3.5.1 Age at which drugs first taken 
All adults aged 16 and over who reported having ever taken drugs were asked what 
age they were when they first took drugs. Figure 3.6 shows that: 
 The most common age for first trying drugs was the late teens (16-19) with 
over half (51.2%) of those who had reported taking drugs at some point in 
their lives first trying them at this age; 
                                               
35 Base sizes: Gender (Male: 340 Female: 160) : Age: (16-24: 130, 25-44: 280, 45-59: 80; 60+: #) 
Socio-economic groups (Manage & Prof: 80, Intermediate: 80, Routine and Man: 160, NW & LTU: 
140), housing tenure groups (Owner occupied: 170, Social rented: 190, Private rented: 120) and 
SIMD index (15% most: 100, Rest of Scotland: 400) 
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 Around one quarter of adults (24.2%) said that they had first used drugs aged 
under 16 and of those 0.8% said that they were less than 10 years old when 
they first tried drugs; 
 A small proportion of adults reported first trying drugs aged over 30 (3.5%). 
 
Figure 3.6: Age at which drugs were first taken   
SCJS 2012/13    
 
Base: adults aged 16 or over who had ever used at least one illicit drug (2170) 
Variable Name: QDRAGE 
 
3.5.2 Variations in the age at which drugs first taken 
Age at which drugs were first taken was significantly36 associated with gender, socio-
economic classification, housing tenure, victim status and area deprivation. The 
strongest differences37 were in relation to socio-economic group and housing tenure.   
 Men were more likely to report first taking drugs aged less than 16 (27.2%) in 
comparison to women (19.5%); 
 Victims of crime were more likely to report first taking drugs aged less than 16 
(31.2%) in comparison to non-victims (21.8%); 
 Adults in routine & manual work (29.2%) and adults classified as not working 
or long-term unemployed (29%) were more likely to report having first taken 
drugs aged less than 16 than those in intermediate occupations (23.7%) and 
those in managerial and professional occupations (16.1%); 
                                               
36 Significant at the p < 0.001 level. 
37 Strength of association measured using Phi/Cramer‟s V tests. 
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 Those living in socially rented housing were more likely to report first taking 
drugs aged less than 16 (37.8%) than those living in private accommodation 
(25.9%) and owner-occupiers (16.9%); 
 Those living in the SIMD 15% most deprived areas were more likely to report 
first taking drugs aged less than 16 (30.6%) compared with those not living in 
these areas (23%). 
 
3.5.3 First drug ever used 
Respondents who had ever used one or more illicit drugs were asked what the first 
drug they had ever used was (see figure 3.7).  
 The majority of adults reported that their first drug used was cannabis 
(79.7%). 
 Over one in ten adults (11.9%) reported that their first drug used was any 
stimulant drug with 3.5% having first tried ecstasy and 3.3% stated 
amphetamines, 3.2% stated poppers and 1.6% stated cocaine as their first 
drug used. 
 3.7% said that their first drug used was a psychedelic drug including 2.1% that 
stated magic mushrooms and 1.6% that stated LSD as first drug used. 
 0.8% of adults reported that their first drug used was any 
tranquilisers/downers.  
 2.9% said that their first drug used was glues, solvents, gas or aerosols.  
 0.3% of adults reported that their first drug used the opiate drug heroin. 
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Figure 3.7: First drug ever used 
SCJS 2012/13 
 
Base: Adults aged 16 or over who had ever used at least one illicit drug (2,170) 
Variable Name: QDR1ST 
Cannabis was the most commonly stated drug first used for all age ranges. Adults 
who first used drugs aged over 25 were more likely to report tranquilisers/downers 
as their first drug used (5.5%) in comparison to 0.8% of all adults. Of those who were 
under 16 years when they first used drugs, 10.8% said that their drug first used was 
either glues, solvents, gas or aerosols, this compares with a much lower first use of 
glues, solvents etc. by those aged 16-19 (0.5%) and those aged 20 or over (0.4%).  
3.5.4 Methods of taking drugs ever tried 
Of those adults who reported having used drugs  at some point in their lives, the 
majority (92.2%) said that that they had taken them by smoking, sniffing or inhaling 
them. Around two in five (41.3%) also reported that they had tried to swallow, eat or 
drink drugs. 2.1% of adults said that they had injected drugs and 0.7% said that they 
had used another method.   
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ANNEX 1: 2012/13 DATA TABLES 
The following tables provide data for some of the key measures of illicit drugs use. 
Notes on how to read and interpret these tables are given below 
Notes: 
The classification of drugs used in this report is detailed in section 1.5. 
 
The definition of time periods shown are: 
Ever: at any time in an individual‟s life 
In the last year: in the 12 months prior to interview 
In the last month: in the month prior to interview 
 
Base figures are shown in the bottom row of Annex 1 tables. Class refers to the legal 
classification of drugs. Composite drug groups include: 
Any stimulants: cocaine, crack, crystal meth, ecstasy, amphetamines and poppers 
Any opiates: heroin and methadone/ physeptone 
Any psychedelics: LSD, magic mushrooms and ketamine 
Any downers / tranquilisers: temazepam and valium 
Any new drugs: BZP, GBL, khat, mephedrone, synthetic cannabinoids (SC) and 
salvia divinorum (SD) 
 
Table abbreviations 
„-‟ indicates that no respondents gave an answer in the category 
„*‟ indicates an answer of less than 0.05% 
#  indicates that base is < 50  
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Data Tables Contents: 
Table A1.1:  % of adults aged 16 or over who reported having ever used illicit 
drugs, used illicit drugs in the last year, and used illicit drugs in the last month 
Table A1.2A:  % of adults aged 16 or over who reported having ever used illicit 
drugs, 2008/09 vs 2009/10 vs 2010/11 vs 2012/13 
Table A1.2B:  % of adults aged 16 or over who reported having in the last 12 
months used illicit drugs, 2008/09 vs 2009/10 vs 2010/11 vs 2012/13 
Table A1.2C:  % of adults aged 16 or over who reported having in the last month 
used illicit drugs, 2008/09 vs 2009/10 vs 2010/11 vs 2012/13 
Table A1.3:  % of adults aged 16 or over who reported having ever used illicit drugs, 
used illicit drugs in the last year, and used illicit drugs in the last month by gender 
Table A1.4:  % of adults aged 16 or over who reported having ever used illicit drugs 
by age group 
Table A1.5:  % of adults aged 16 or over who reported having used illicit drugs in the 
last year by age group 
Table A1.6:  % of adults aged 16 or over who reported having used illicit drugs in the 
last month by age group 
Table A1.7 % of men aged 16 or over who reported having ever used illicit drugs by 
age group 
Table A1.8 % of men aged 16 or over who reported having used illicit drugs in the 
last year by age group 
Table A1.9 % of men aged 16 or over who reported having used illicit drugs in the 
last month by age group 
Table A1.10 % of women aged 16 or over who reported having ever used illicit 
drugs by age group 
Table A1.11 % of women aged 16 or over who reported having used illicit drugs in 
the last year by age group 
Table A1.12 % of women aged 16 or over who reported having used illicit drugs in 
the last month by age group 
Table A1.13: Type of drug first taken and age at which first taken among men 
who reported ever using illicit drugs 
Table A1.14 Type of drug first taken and age at which first taken among women 
who reported ever using illicit drugs 
Table A1.15 % of men aged 16 or over who reported someone having offered to 
sell or give them drugs in the last year by age group 
Table A1.16 % of women aged 16 or over who reported someone having offered to 
sell or give them drugs in the last year by age group 
Table A1.17 Polydrug and drug and alcohol use in the last 12 months among 
adults over 16 using illicit drugs in the last 12 months 
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Table A1.1:  % of adults aged 16 or over who reported having ever used illicit 
drugs, used illicit drugs in the last year, and used illicit drugs in the last month 
SCJS 2012/13 
Percentage of all adults aged 16 and 
over Ever  
In last 
year 
In last 
month 
CLASS A 12.9 2.6 1.1 
Cocaine 7.2 1.7 0.6 
Crack 0.7 0.2 * 
Ecstasy 7.8 1.3 0.3 
Heroin 1.0 0.3 0.2 
Methadone/Physeptone 0.7 0.1 0.1 
LSD 5.2 0.2 0.1 
Magic mushrooms 5.4 0.2 * 
CLASS B 21.6 5.3 2.8 
Amphetamines 7.8 0.7 0.2 
Crystal Meth 0.3 * - 
Cannabis 21.1 5.1 2.7 
CLASS C 3.8 1.0 0.4 
Anabolic Steroids 0.5 0.2 0.1 
Ketamine 1.5 0.2 0.1 
Tranquilisers 2.8 0.8 0.3 
NOT CLASSIFIED       
Glues/solvents/gas/aerosols 1.9 0.1 * 
Poppers 5.8 0.5 0.1 
NEW DRUGS 2.3 0.5 0.1 
Mephedrone 1.4 0.4 0.1 
BZP, GBL, Khat, SC or SD 1.4 0.2 * 
ANY STIMULANTS 12.3 2.6 1.0 
ANY OPIATES 1.1 0.3 0.2 
ANY PSYCHEDELICS 7.5 0.4 0.1 
ANY DOWNERS / TRANQUILISERS 2.8 0.8 0.3 
ANY DRUGS 23.0 6.2 3.3 
ANY DRUGS EX. NEW DRUGS 23.0 6.2 3.3 
Base (All respondents): 10,220 10,220 10,220 
 
Variable Names: QEVE, Q12M, Q1M 
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Table A1.2A: % of adults aged 16 or over who reported having ever used illicit 
drugs, 2008/09, 2009/10, 2010/11, 2012/13 
SCJS 2008/09; 2009/10; 2010/11; 2012/13 
 
At some point in their lives 
Percentage of all adults aged 16 and 
over 2008/09 2009/10 2010/11 2012/13 
CLASS A 11.7 11.7 11.7 12.9 
Cocaine 6.6 6.7 7.1 7.2 
Crack 0.7 0.7 0.8 0.7 
Ecstasy 7.2 7.4 7.2 7.8 
Heroin 0.9 0.9 0.7 1.0 
Methadone/Physeptone 0.6 0.6 0.7 0.7 
LSD 4.9 4.6 4.9 5.2 
Magic mushrooms 5.5 5.3 5.2 5.4 
CLASS B 23.6 23.5 22.2 21.6 
Amphetamines 7.5 7.6 7.8 7.8 
Crystal Meth 0.2 0.2 0.3 0.3 
Cannabis 22.9 22.9 21.6 21.1 
CLASS C 5.7 4.8 5.2 3.8 
Anabolic Steroids 0.5 0.4 0.3 0.5 
Ketamine 1.2 1.3 1.2 1.5 
Temazepam* 2.5 2.1 2.0 - 
Valium* 4.2 3.4 3.9 - 
Any Downers / Tranquilisers 5.0 4.1 4.6 2.8 
NOT CLASSIFIED 
    Glues/solvents/gas/aerosols 2.3 2.0 2.2 1.9 
Poppers 6.5 6.6 6.4 5.8 
ANY STIMULANTS 12.6 12.7 12.5 12.3 
ANY OPIATES 1.1 1.0 1.0 1.1 
ANY PSYCHEDELICS 7.7 7.6 7.5 7.5 
ANY DOWNERS / TRANQUILISERS 5.0 4.1 4.6 2.8 
ANY DRUGS 25.6 25.2 23.7 23.0 
Base (All respondents): 10,960 13,410 10,980 10,220 
 
Variable Name: QEVE 
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Table A1.2B:  % of adults aged 16 or over who reported having in the last 12 
months used illicit drugs, 2008/09, 2009/10, 2010/11, 2012/13 
 SCJS 2008/09; 2009/10; 2010/11; 2012/13 
  In the last 12 months 
Percentage of all adults aged 16 and 
over 2008/09 2009/10 2010/11 2012/13 
CLASS A 3.4 3.0 2.6 2.6 
Cocaine 2.7 2.1 1.9 1.7 
Crack 0.2 0.1 1.9 0.2 
Ecstasy 1.8 1.9 1.4 1.3 
Heroin 0.2 0.3 0.2 0.3 
Methadone/Physeptone 0.2 0.3 0.2 0.1 
LSD 0.4 0.2 0.2 0.2 
Magic mushrooms 0.4 0.3 0.3 0.2 
CLASS B 6.4 6.2 5.7 5.3 
Amphetamines 1.0 1.0 0.9 0.7 
Crystal Meth * * * * 
Cannabis 6.2 6.1 5.6 5.1 
CLASS C 1.3 1.3 1.2 1.0 
Anabolic Steroids 0.1 * 0.1 0.2 
Ketamine 0.2 0.3 0.3 0.2 
Temazepam* 0.4 0.4 0.3 - 
Valium* 1.1 0.9 1.0 - 
Any Downers / Tranquilisers 1.2 1.0 1.1 0.8 
NOT CLASSIFIED         
Glues/solvents/gas/aerosols 0.1 0.1 0.2 0.1 
Poppers 1.0 0.9 0.6 0.5 
ANY STIMULANTS 3.9 3.3 2.8 2.6 
ANY OPIATES 0.3 0.4 0.3 0.3 
ANY PSYCHEDELICS 0.7 0.7 0.6 0.4 
ANY DOWNERS / TRANQUILISERS 1.2 1.0 1.1 0.8 
ANY DRUGS 7.6 7.2 6.7 6.2 
Base (All respondents): 10,960 13,410 10,980 10,220 
*Separate data on Temazepam and Valium not available 2012/13 
   
Variable Name: Q12M 
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Table A1.2C:  % of adults aged 16 or over who reported having in the last 
month used illicit drugs, 2008/09 vs 2009/10 vs 2010/11 vs 2012/13 
SCJS 2008/09; 2009/10; 2010/11; 2012/13 
 
In the last month 
Percentage of all adults aged 16 and 
over 2008/09 2009/10 2010/11 2012/13 
CLASS A 1.8 1.3 1.2 1.1 
Cocaine 1.2 0.7 0.7 0.6 
Crack 0.1 0.1 0.1 * 
Ecstasy 0.8 0.7 0.6 0.3 
Heroin 0.1 0.2 0.1 0.2 
Methadone/Physeptone 0.2 0.2 0.2 0.1 
LSD 0.1 0.1 0.1 0.1 
Magic mushrooms 0.2 0.1 0.1 * 
CLASS B 3.6 3.7 3.0 2.8 
Amphetamines 0.4 0.3 0.4 0.2 
Crystal Meth * * - - 
Cannabis 3.5 3.6 2.7 2.7 
CLASS C 0.8 0.6 0.5 0.4 
Anabolic Steroids * * 0.1 0.1 
Ketamine 0.1 0.1 0.1 0.1 
Temazepam* 0.1 0.2 0.1 - 
Valium* 0.6 0.5 0.4 - 
Tranquilisers 0.6 0.5 0.3 0.3 
NOT CLASSIFIED 
    Glues/solvents/gas/aerosols * * * * 
Poppers 0.3 0.2 0.1 0.1 
ANY STIMULANTS 1.9 1.3 1.2 1.0 
ANY OPIATES 0.2 0.3 0.2 0.2 
ANY PSYCHEDELICS 0.3 0.2 0.2 0.1 
ANY DOWNERS / TRANQUILISERS 0.6 0.5 0.4 0.3 
ANY DRUGS 4.4 4.2 3.5 3.3 
Base (All respondents): 10,960 13,410 10,980 10,220 
*Separate data on Temazepam and Valium not available 2012/13 
   
Variable Name: Q1M 
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Table A1.3:  % of adults aged 16 or over who reported having ever used illicit 
drugs, used illicit drugs in the last year, and used illicit drugs in the last month 
by gender 
SCJS 2012/13 
 
Ever In last year In last month 
Percentage of all adults aged 16 
and over Men Women Men Women Men Women 
CLASS A 17.3 8.9 4.1 1.3 1.9 0.4 
Cocaine 10.3 4.3 2.7 0.8 1.2 0.2 
Crack 1.0 0.3 0.2 0.1 0.1 * 
Ecstasy 10.9 5.0 2.2 0.5 0.5 * 
Heroin 1.4 0.6 0.4 0.1 0.3 0.1 
Methadone/Physeptone 0.9 0.5 0.2 0.1 0.1 0.2 
LSD 7.8 2.7 0.4 * 0.1 - 
Magic mushrooms 8.3 2.7 0.4 * 0.1 - 
CLASS B 27.7 15.9 8.0 2.9 4.3 1.4 
Amphetamines 10.6 5.2 1.1 0.3 0.3 0.1 
Crystal Meth 0.4 0.1 * - - - 
Cannabis 27.3 15.4 7.7 2.8 4.2 1.3 
CLASS C 5.7 2.0 1.9 0.3 0.7 0.1 
Anabolic Steroids 1.0 * 0.3 * 0.1 - 
Ketamine 2.4 0.6 0.3 * 0.1 - 
Tranquilisers 4.1 1.7 1.4 0.2 0.5 0.1 
NOT CLASSIFIED 
      Glues/solvents/gas/aerosols 3.0 1.0 0.2 * 0.1 - 
Poppers 8.4 3.3 0.9 0.1 0.3 - 
NEW DRUGS 3.6 1.1 0.8 0.2 0.2 * 
Mephedrone 2.2 0.7 0.6 0.2 0.1 * 
BZP, GBL, Khat, SC or SD 2.3 0.5 0.3 0.1 0.1 * 
ANY STIMULANTS 16.3 8.7 4.1 1.2 1.7 0.3 
ANY OPIATES 1.6 0.7 0.5 0.2 0.3 0.2 
ANY PSYCHEDELICS 11.2 4.2 0.8 0.1 0.3 - 
ANY DOWNERS / 
TRANQUILISERS 4.1 1.7 1.4 0.2 0.5 0.1 
ANY DRUGS 29.4 17.2 9.4 3.3 5.3 1.6 
ANY DRUGS EX. NEW DRUGS 29.3 17.2 9.4 3.3 5.3 1.6 
Base: 4,420 5,800 4,420 5,800 4,420 5,800 
 
Variable Name: QEVE, Q12M, Q1M  
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Table A1.4:  % of adults aged 16 or over who reported having ever used illicit 
drugs by age group 
SCJS 2012/13 
  At some point in their lives   
Percentage of all adults aged 16 and 
over within group 
All 
adults 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
16 - 
59 
CLASS A 12.9 16.9 24.7 9.1 1.1 17.6 
Cocaine 7.2 11.6 14.5 3.4 0.1 10.0 
Crack 0.7 0.3 1.5 0.5 * 0.9 
Ecstasy 7.8 10.8 17.3 2.9 * 10.9 
Heroin 1.0 0.2 2.0 1.1 0.1 1.3 
Methadone/Physeptone 0.7 0.4 1.6 0.5 - 1.0 
LSD 5.2 2.8 10.9 4.4 0.5 7.0 
Magic mushrooms 5.4 4.6 10.7 4.7 0.4 7.3 
CLASS B 21.6 28.3 36.9 18.0 4.0 28.5 
Amphetamines 7.8 7.5 16.2 5.7 0.3 10.7 
Crystal Meth 0.3 - 0.4 0.5 * 0.4 
Cannabis 21.1 28.2 35.6 17.8 4.0 27.8 
CLASS C 3.8 4.7 8.2 1.6 0.2 5.1 
Anabolic Steroids 0.5 1.2 0.9 0.2 * 0.7 
Ketamine 1.5 2.5 3.1 0.5 - 2.0 
Tranquilisers 2.8 2.5 6.6 1.2 0.2 3.9 
NOT CLASSIFIED             
Glues/solvents/gas/aerosols 1.9 2.1 4.1 1.2 - 2.7 
Poppers 5.8 7.0 12.4 3.0 0.1 8.0 
NEW DRUGS 2.3 6.1 3.8 0.7 * 0.0 
Mephedrone 1.4 4.1 2.2 0.4 - 2.0 
BZP, GBL, Khat, SC or SD 1.4 4.0 2.2 0.5 * 1.9 
ANY STIMULANTS 12.3 17.5 24.3 7.6 0.5 17.0 
ANY OPIATES 1.1 0.5 2.3 1.2 0.1 1.6 
ANY PSYCHEDELICS 7.5 6.3 15.0 6.5 0.8 10.2 
ANY DOWNERS / 
TRANQUILISERS 2.8 2.5 6.6 1.2 0.2 3.9 
ANY DRUGS 23.0 31.3 39.1 18.9 4.3 30.4 
ANY DRUGS EX. NEW DRUGS 23.0 31.2 39.0 18.9 4.3 30.3 
Base: 10,220 860 3,100 2,730 3,540 6,690 
 
Variable Name: QEVE 
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Table A1.5:  % of adults aged 16 or over who reported having used illicit drugs 
in the last year by age group 
SCJS 2012/13 
  In the last year   
Percentage of all adults aged 16 and 
over within group 
All 
adults 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
16 - 
59 
CLASS A 2.6 5.9 4.9 0.8 - 3.7 
Cocaine 1.7 3.7 3.3 0.4 - 2.4 
Crack 0.2 0.1 0.3 0.1 - 0.2 
Ecstasy 1.3 3.4 2.5 0.2 - 1.8 
Heroin 0.3 0.1 0.6 0.2 - 0.4 
Methadone/Physeptone 0.1 0.1 0.3 0.1 - 0.2 
LSD 0.2 0.4 0.4 - - 0.3 
Magic mushrooms 0.2 0.9 0.1 0.1 - 0.3 
CLASS B 5.3 14.0 8.2 2.3 0.3 7.3 
Amphetamines 0.7 1.8 1.1 0.3 - 0.9 
Crystal Meth * - 0.0 - - * 
Cannabis 5.1 13.8 7.8 2.3 0.3 7.1 
CLASS C 1.0 2.4 1.9 0.3 - 1.4 
Anabolic Steroids 0.2 0.6 0.3 - - 0.2 
Ketamine 0.2 0.5 0.3 - - 0.2 
Tranquilisers 0.8 1.3 1.6 0.3 - 1.1 
NOT CLASSIFIED             
Glues/solvents/gas/aerosols 0.1 0.6 0.1 - - 0.2 
Poppers 0.5 1.6 0.8 0.1 - 0.7 
NEW DRUGS 0.5 2.1 0.6 0.1 - 0.0 
Mephedrone 0.4 1.6 0.5 0.1 - 0.5 
BZP, GBL, Khat, SC or SD 0.2 0.7 0.2 - - 0.2 
ANY STIMULANTS 2.6 5.9 4.9 0.6 - 3.6 
ANY OPIATES 0.3 0.1 0.8 0.3 - 0.5 
ANY PSYCHEDELICS 0.4 1.3 0.7 0.1 - 0.6 
ANY DOWNERS / 
TRANQUILISERS 0.8 1.3 1.6 0.3 - 1.1 
ANY DRUGS 6.2 16.4 9.7 2.5 0.3 8.5 
ANY DRUGS EX. NEW DRUGS 6.2 16.4 9.7 2.5 0.3 8.5 
Base: 10,220 860 3,100 2,730 3,540 6,690 
 
Variable Name: Q12M 
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Table A1.6:  % of adults aged 16 or over who reported having used illicit drugs 
in the last month by age group 
SCJS 2012/13 
  In the last month   
Percentage of all adults aged 16 
and over within group 
All 
adults 
16 - 
24 
25 - 
44 
45 - 
59 60+ 16 - 59 
CLASS A 1.1 3.0 1.9 0.4 - 1.6 
Cocaine 0.6 1.9 1.0 0.2 - 0.9 
Crack * - 0.1 0.1 - 0.1 
Ecstasy 0.3 1.0 0.4 * - 0.4 
Heroin 0.2 * 0.4 0.1 - 0.2 
Methadone/Physeptone 0.1 0.1 0.2 0.1 - 0.1 
LSD 0.1 0.1 0.1 - - 0.1 
Magic mushrooms * 0.2 - - - 0.1 
CLASS B 2.8 6.7 4.2 1.6 0.3 3.8 
Amphetamines 0.2 0.3 0.5 * - 0.3 
Crystal Meth - - - - - - 
Cannabis 2.7 6.4 4.0 1.6 0.3 3.6 
CLASS C 0.4 0.6 0.8 0.2 - 0.5 
Anabolic Steroids 0.1 0.2 0.1 - - 0.1 
Ketamine 0.1 0.3 0.1 - - 0.1 
Tranquilisers 0.3 0.1 0.6 0.2 - 0.4 
NOT CLASSIFIED             
Glues/solvents/gas/aerosols * 0.2 - - - 0.1 
Poppers 0.1 0.4 0.1 0.1 - 0.2 
NEW DRUGS 0.1 0.5 0.1 * - 0.1 
Mephedrone 0.1 0.3 0.1 * - 0.1 
BZP, GBL, Khat, SC or SD * 0.2 * - - 0.1 
ANY STIMULANTS 1.0 3.0 1.5 0.3 - 1.4 
ANY OPIATES 0.2 0.1 0.5 0.2 - 0.3 
ANY PSYCHEDELICS 0.1 0.4 0.2 - - 0.2 
ANY DOWNERS / 
TRANQUILISERS 0.3 0.1 0.6 0.2 - 0.4 
ANY DRUGS 3.3 8.4 5.0 1.7 0.3 4.5 
ANY DRUGS EX. NEW DRUGS 3.3 8.4 5.0 1.7 0.3 4.5 
Base: 10,220 860 3,100 2,730 3,540 6,690 
 
Variable Name: Q1M 
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Table A1.7 % of men aged 16 or over who reported having ever used illicit 
drugs by age group 
SCJS 2012/13 
 
Ever - Men 
Percentage of all men aged 16 and over 
within group 
All 
Men 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 17.3 20.2 31.9 12.9 1.6 
Cocaine 10.3 13.5 20.5 5.7 0.2 
Crack 1.0 0.3 2.3 1.0 - 
Ecstasy 10.9 12.5 23.6 4.5 0.1 
Heroin 1.4 0.2 2.7 1.7 0.2 
Methadone/Physeptone 0.9 0.4 2.0 0.8 - 
LSD 7.8 4.1 15.5 7.4 0.8 
Magic mushrooms 8.3 7.6 15.7 6.8 0.8 
CLASS B 27.7 33.9 45.1 23.3 6.6 
Amphetamines 10.6 9.3 21.0 8.3 0.6 
Crystal Meth 0.4 - 0.7 0.8 - 
Cannabis 27.3 33.9 43.9 23.1 6.6 
CLASS C 5.7 6.2 12.0 2.6 0.4 
Anabolic Steroids 1.0 2.3 1.7 0.3 0.1 
Ketamine 2.4 3.1 5.1 0.8 - 
Tranquilisers 4.1 3.4 9.1 2.0 0.3 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols 3.0 2.8 6.1 2.2 - 
Poppers 8.4 7.9 18.1 4.8 0.1 
NEW DRUGS 3.6 0.1 0.1 0.0 * 
Mephedrone 2.2 5.3 3.5 0.7 - 
BZP, GBL, Khat, SC or SD 2.3 6.4 3.4 0.9 * 
ANY STIMULANTS 16.3 19.5 31.0 11.1 0.9 
ANY OPIATES 1.6 0.4 2.9 1.9 0.2 
ANY PSYCHEDELICS 11.2 9.4 21.2 9.4 1.2 
ANY DOWNERS / TRANQUILISERS 4.1 3.4 9.1 2.0 0.3 
ANY DRUGS 29.4 36.5 47.8 24.5 6.8 
ANY DRUGS EX. NEW DRUGS 29.3 36.4 47.6 24.5 6.8 
Base: 4,420 380 1,310 1,170 1,560 
 
Variable Name: QEVE 
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Table A1.8 % of men aged 16 or over who reported having used illicit drugs in 
the last year by age group 
SCJS 2012/13 
 
In the last year - Men 
Percentage of all men aged 16 and 
over within group 
All 
Men 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 4.1 8.9 7.4 1.2 - 
Cocaine 2.7 4.9 5.2 0.8 - 
Crack 0.2 0.2 0.5 0.3 - 
Ecstasy 2.2 5.1 3.9 0.3 - 
Heroin 0.4 0.1 0.8 0.5 - 
Methadone/Physeptone 0.2 0.1 0.4 0.1 - 
LSD 0.4 0.6 0.8 - - 
Magic mushrooms 0.4 1.8 0.3 - - 
CLASS B 8.0 18.5 12.4 3.6 0.6 
Amphetamines 1.1 2.8 1.8 0.5 - 
Crystal Meth * - 0.1 - - 
Cannabis 7.7 18.3 11.8 3.5 0.6 
CLASS C 1.9 4.1 3.3 0.5 - 
Anabolic Steroids 0.3 1.1 0.5 - - 
Ketamine 0.3 1.0 0.5 - - 
Tranquilisers 1.4 2.1 2.7 0.5 - 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols 0.2 1.1 0.1 - - 
Poppers 0.9 2.7 1.4 0.3 - 
NEW DRUGS 0.1 3.2 1.0 0.1 - 
Mephedrone 0.6 2.4 0.7 0.1 - 
BZP, GBL, Khat, SC or SD 0.3 1.2 0.3 - - 
ANY STIMULANTS 4.1 8.7 7.5 1.1 - 
ANY OPIATES 0.5 0.1 1.0 0.5 - 
ANY PSYCHEDELICS 0.8 2.4 1.3 - - 
ANY DOWNERS / 
TRANQUILISERS 1.4 2.1 2.7 0.5 - 
ANY DRUGS 9.4 22.1 14.8 3.8 0.6 
ANY DRUGS EX. NEW DRUGS 9.4 22.1 14.8 3.8 0.6 
Base: 4,420 380 1,310 1,170 1,560 
 
Variable Name: Q12M 
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Table A1.9 % of men aged 16 or over who reported having used illicit drugs in 
the last month by age group 
SCJS 2012/13 
 
In the last month - Men 
Percentage of all men aged 16 and 
over within group 
All 
Men 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 1.9 4.6 3.2 0.7 - 
Cocaine 1.2 3.3 1.6 0.5 - 
Crack 0.1 - 0.1 0.2 - 
Ecstasy 0.5 1.8 0.8 * - 
Heroin 0.3 0.1 0.6 0.3 - 
Methadone/Physeptone 0.1 - 0.2 0.1 - 
LSD 0.1 0.2 0.3 - - 
Magic mushrooms 0.1 0.5 - - - 
CLASS B 4.3 9.4 6.3 2.5 0.6 
Amphetamines 0.3 0.2 0.9 * - 
Crystal Meth - - - - - 
Cannabis 4.2 9.4 6.0 2.5 0.6 
CLASS C 0.7 1.1 1.4 0.5 - 
Anabolic Steroids 0.1 0.4 0.2 - - 
Ketamine 0.1 0.5 0.2 - - 
Tranquilisers 0.5 0.2 1.1 0.5 - 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols 0.1 0.5 - - - 
Poppers 0.3 0.7 0.3 0.3 - 
NEW DRUGS 0.2 0.8 0.2 * - 
Mephedrone 0.1 0.6 0.1 * - 
BZP, GBL, Khat, SC or SD 0.1 0.2 0.1 - - 
ANY STIMULANTS 1.7 4.7 2.6 0.6 - 
ANY OPIATES 0.3 0.1 0.7 0.4 - 
ANY PSYCHEDELICS 0.3 0.8 0.4 - - 
ANY DOWNERS / 
TRANQUILISERS 0.5 0.2 1.1 0.5 - 
ANY DRUGS 5.3 12.1 7.8 2.7 0.6 
ANY DRUGS EX. NEW DRUGS 5.3 12.1 7.8 2.7 0.6 
Base: 4,420 380 1,310 1,170 1,560 
 
Variable Name: Q1M 
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Table A1.10 % of women aged 16 or over who reported having ever used illicit 
drugs by age group 
SCJS 2012/13 
 
Ever - Women 
Percentage of all women aged 16 and 
over within group 
All 
Women 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 8.9 13.4 17.7 5.5 0.7 
Cocaine 4.3 9.5 8.7 1.3 * 
Crack 0.3 0.2 0.8 0.1 0.1 
Ecstasy 5.0 9.0 11.1 1.4 - 
Heroin 0.6 0.3 1.4 0.5 - 
Methadone/Physeptone 0.5 0.4 1.3 0.1 - 
LSD 2.7 1.4 6.4 1.6 0.3 
Magic mushrooms 2.7 1.5 5.7 2.7 0.1 
CLASS B 15.9 22.4 29.0 13.1 1.9 
Amphetamines 5.2 5.6 11.5 3.2 0.1 
Crystal Meth 0.1 - 0.2 0.1 * 
Cannabis 15.4 22.3 27.6 12.8 1.9 
CLASS C 2.0 3.0 4.5 0.6 0.1 
Anabolic Steroids * - 0.1 0.1 - 
Ketamine 0.6 1.9 1.1 0.1 - 
Tranquilisers 1.7 1.5 4.2 0.5 0.1 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols 1.0 1.4 2.1 0.4 - 
Poppers 3.3 6.0 7.0 1.4 * 
NEW DRUGS 1.1 4.0 1.8 0.1 - 
Mephedrone 0.7 2.8 1.0 0.1 - 
BZP, GBL, Khat, SC or SD 0.5 1.4 1.0 0.1 - 
ANY STIMULANTS 8.7 15.3 17.7 4.2 0.3 
ANY OPIATES 0.7 0.6 1.7 0.5 - 
ANY PSYCHEDELICS 4.2 3.0 8.8 3.7 0.4 
ANY DOWNERS / TRANQUILISERS 1.7 1.5 4.2 0.5 0.1 
ANY DRUGS 17.2 25.8 30.6 13.7 2.2 
ANY DRUGS EX. NEW DRUGS 17.2 25.7 30.6 13.7 2.2 
Base: 5,800 480 1,800 1,560 1,980 
 
Variable name: QEVE 
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Table A1.11 % of women aged 16 or over who reported having used illicit 
drugs in the last year by age group 
SCJS 2012/13 
 
In the last year - Women 
Percentage of all women aged 16 
and over within group 
All 
Women 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 1.3 2.7 2.5 0.4 - 
Cocaine 0.8 2.4 1.4 0.1 - 
Crack 0.1 - 0.2 - - 
Ecstasy 0.5 1.6 1.1 - - 
Heroin 0.1 0.1 0.4 - - 
Methadone/Physeptone 0.1 0.1 0.3 0.1 - 
LSD * 0.2 - - - 
Magic mushrooms * - * 0.1 - 
CLASS B 2.9 9.4 4.0 1.2 0.1 
Amphetamines 0.3 0.7 0.4 0.1 - 
Crystal Meth - - - - - 
Cannabis 2.8 9.1 3.8 1.2 0.1 
CLASS C 0.3 0.5 0.6 * - 
Anabolic Steroids * - 0.1 - - 
Ketamine * - 0.1 - - 
Tranquilisers 0.2 0.5 0.5 * - 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols * - * - - 
Poppers 0.1 0.3 0.3 - - 
NEW DRUGS 0.2 1.0 0.3 * - 
Mephedrone 0.2 0.9 0.2 * - 
BZP, GBL, Khat, SC or SD 0.1 0.1 0.1 - - 
ANY STIMULANTS 1.2 3.0 2.5 0.2 - 
ANY OPIATES 0.2 0.1 0.5 0.1 - 
ANY PSYCHEDELICS 0.1 0.2 0.1 0.1 - 
ANY DOWNERS / 
TRANQUILISERS 0.2 0.5 0.5 * - 
ANY DRUGS 3.3 10.5 4.8 1.4 0.1 
ANY DRUGS EX. NEW DRUGS 3.3 10.5 4.8 1.4 0.1 
Base: 5,800 480 1,800 1,560 1,980 
 
Variable name: Q12M 
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Table A1.12 % of women aged 16 or over who reported having used illicit 
drugs in the last month by age group 
SCJS 2012/13 
  In the last month - Women 
Percentage of all women aged 16 
and over within group 
All 
Women 
16 - 
24 
25 - 
44 
45 - 
59 60+ 
CLASS A 0.4 1.3 0.7 0.1 - 
Cocaine 0.2 0.5 0.3 - - 
Crack * - * - - 
Ecstasy * 0.2 0.1 - - 
Heroin 0.1 - 0.2 - - 
Methadone/Physeptone 0.1 0.1 0.2 0.1 - 
LSD - - - - - 
Magic mushrooms - - - - - 
CLASS B 1.4 3.8 2.1 0.8 0.1 
Amphetamines 0.1 0.5 0.1 0.1 - 
Crystal Meth - - - - - 
Cannabis 1.3 3.3 2.0 0.8 0.1 
CLASS C 0.1 - 0.2 * - 
Anabolic Steroids - - - - - 
Ketamine - - - - - 
Tranquilisers 0.1 - 0.2 * - 
NOT CLASSIFIED           
Glues/solvents/gas/aerosols - - - - - 
Poppers - - - - - 
NEW DRUGS * 0.1 * - - 
Mephedrone * - * - - 
BZP, GBL, Khat, SC or SD * 0.1 - - - 
ANY STIMULANTS 0.3 1.2 0.5 0.1 - 
ANY OPIATES 0.2 0.1 0.4 0.1 - 
ANY PSYCHEDELICS - - - - - 
ANY DOWNERS / 
TRANQUILISERS 0.1 - 0.2 * - 
ANY DRUGS 1.6 4.5 2.4 0.8 0.1 
ANY DRUGS EX. NEW DRUGS 1.6 4.5 2.4 0.8 0.1 
Base: 5,800 480 1,800 1,560 1,980 
 
Variable name: Q1M 
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Table A1.13: Type of drug first taken and age at which first taken among men 
who reported ever using illicit drugs 
SCJS 2012/13 
    Age took first drug 
Percentage of all men aged 16 and 
over who ever took drugs within 
group 
All men 
reporting 
drug use 
Under 
16 16-19 20-24 
25 
or 
over 
CLASS A 11.4 7.7 12.4 14.8 10.9 
Cocaine 1.7 0.5 1.7 3.3 2.1 
Crack * - 0.1 - - 
Ecstasy 2.7 0.9 3.2 3.9 4.4 
Heroin 0.2 0.3 0.3 - - 
Methadone/Physeptone - - - - - 
LSD 1.6 0.9 2.3 0.5 2.2 
Magic mushrooms 2.4 3.6 2.4 0.9 2.2 
CLASS B 82.9 79.0 85.6 85.2 77.3 
Amphetamines 2.7 1.6 2.3 6.2 - 
Crystal Meth - - - - - 
Cannabis 80.2 77.4 83.2 78.9 77.3 
CLASS C 1.1 0.3 0.3 2.5 8.5 
Anabolic Steroids 0.3 - 0.1 0.8 1.6 
Ketamine - - - - - 
Tranquilisers 0.8 0.3 0.2 1.7 6.9 
NOT CLASSIFIED           
Glues/solvents/gas/aerosols 3.6 11.7 0.9 - - 
Poppers 3.0 2.9 3.1 2.7 3.3 
NEW DRUGS 0.2 - 0.1 1.1 - 
Mephedrone * - 0.1 - - 
BZP, GBL, Khat, SC or SD 0.2 - - 1.1 - 
ANY STIMULANTS 10.1 5.9 10.5 16.1 9.8 
ANY OPIATES 0.2 0.3 0.3 - - 
ANY PSYCHEDELICS 4.0 4.4 4.7 1.4 4.4 
ANY DOWNERS / 
TRANQUILISERS 0.8 0.3 0.2 1.7 6.9 
Base: 1,190 300 580 220 80 
 
Variable Names: QDR1ST, QDRAGE 
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Table A1.14 Type of drug first taken and age at which first taken among 
women who reported ever using illicit drugs 
SCJS 2012/13 
  
Age took first drug 
Percentage of all women aged 16 
and over who ever took drugs within 
group 
All 
women 
reporting 
drug use 
Under 
16 16-19 20-24 
25 
or 
over 
CLASS A 14.7 13.9 16.3 12.3 12.1 
Cocaine 1.6 0.4 2.5 0.7 1.1 
Crack 0.4 0.6 0.5 - - 
Ecstasy 4.7 6.3 5.0 3.8 1.6 
Heroin 0.3 - 0.2 1.0 - 
Methadone/Physeptone - - - - - 
LSD 1.7 2.0 1.8 1.4 0.6 
Magic mushrooms 1.6 3.0 1.5 0.3 3.1 
CLASS B 83.3 73.7 84.2 88.4 89.0 
Amphetamines 4.4 1.7 4.9 5.2 5.6 
Crystal Meth * - - - - 
Cannabis 78.8 72.0 79.3 83.2 83.4 
CLASS C 0.8 0.8 0.5 0.4 3.7 
Anabolic Steroids - - - - - 
Ketamine - - - - - 
Tranquilisers 0.8 0.8 0.5 0.4 3.7 
NOT CLASSIFIED 
     Glues/solvents/gas/aerosols 1.8 8.6 0.1 - 0.8 
Poppers 3.7 4.6 3.8 3.7 - 
NEW DRUGS 0.1 - - 0.4 - 
Mephedrone 0.1 - - 0.4 - 
BZP, GBL, Khat, SC or SD - - - - - 
ANY STIMULANTS 14.8 13.6 16.7 13.4 8.4 
ANY OPIATES 0.3 - 0.2 1.0 - 
ANY PSYCHEDELICS 3.3 5.0 3.3 1.7 3.7 
ANY DOWNERS / 
TRANQUILISERS 0.8 0.8 0.5 0.4 3.7 
Base: 990 180 500 210 80 
 
Variable Names: QDR1ST, QDRAGE  
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Table A1.15 % of men aged 16 or over who reported someone having offered 
to sell or give them drugs in the last year by age group 
SCJS 2012/13 
   
All men aged 
Percentage of adults aged 16 and 
over 
All 
adults 
All 
men 16-24 
25-
44 
45-
49 60+ 
CLASS A 6.9 10.0 26.6 14.8 3.9 0.3 
Cocaine 4.7 7.3 21.6 10.5 2.3 - 
Crack 0.5 0.8 1.3 1.2 0.7 - 
Ecstasy 4.0 6.0 18.0 8.4 1.7 * 
Heroin 0.9 1.6 2.6 2.6 1.0 0.2 
Methadone/Physeptone 0.5 0.9 0.2 2.0 0.8 - 
LSD 1.0 1.6 3.8 2.6 0.6 - 
Magic mushrooms 0.7 1.2 3.6 1.6 0.3 0.1 
CLASS B 8.6 12.7 32.9 18.1 5.8 1.0 
Amphetamines 2.2 3.5 8.7 5.3 1.6 - 
Crystal Meth 0.2 0.3 0.3 0.5 0.2 - 
Cannabis 8.3 12.2 31.9 17.2 5.4 1.0 
CLASS C 2.4 3.9 10.7 5.3 1.6 0.4 
Anabolic Steroids 0.6 1.3 4.1 1.8 0.1 0.1 
Ketamine 1.0 1.7 6.4 1.8 0.6 - 
Tranquilisers 1.3 1.8 2.8 3.0 1.2 0.4 
NOT CLASSIFIED 
      Glues/solvents/gas/aerosols 0.2 0.3 1.6 0.1 0.1 0.1 
Poppers 1.2 1.8 5.0 2.5 0.9 - 
NEW DRUGS 1.4 2.1 6.6 2.8 0.6 0.2 
Mephedrone 1.1 1.7 5.1 2.5 0.4 0.1 
BZP, GBL, Khat, SC or SD 0.4 0.6 2.0 0.5 0.2 0.1 
ANY STIMULANTS 6.6 9.5 25.2 14.0 3.8 * 
ANY OPIATES 1.2 1.9 2.8 3.5 1.2 0.2 
ANY PSYCHEDELICS 1.9 3.2 9.9 4.2 1.0 0.1 
ANY DOWNERS / 
TRANQUILISERS 1.3 1.8 2.8 3.0 1.2 0.4 
ANY DRUGS 10.8 15.6 38.4 22.2 7.4 1.9 
ANY DRUGS EXC. NEW DRUGS 10.6 15.5 38.4 22.1 7.3 1.6 
Base: 10,220 4,420 380 1,310 1,170 1,560 
 
Variable Name: QOF2  
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Table A1.16 % of women aged 16 or over who reported someone having 
offered to sell or give them drugs in the last year by age group 
SCJS 2012/13 
   
All women aged 
Percentage of adults aged 16 and 
over 
All 
adults 
All 
women 16-24 
25-
44 
45-
49 60+ 
CLASS A 6.9 4.0 14.1 5.8 1.1 0.1 
Cocaine 4.7 2.2 7.6 3.2 0.6 * 
Crack 0.5 0.2 0.8 0.4 - * 
Ecstasy 4.0 2.2 9.3 2.6 0.4 - 
Heroin 0.9 0.4 0.6 0.8 0.1 * 
Methadone/Physeptone 0.5 0.2 0.3 0.4 0.1 - 
LSD 1.0 0.4 2.2 0.3 - - 
Magic mushrooms 0.7 0.2 1.0 0.3 - - 
CLASS B 8.6 4.8 17.1 6.6 1.6 0.2 
Amphetamines 2.2 1.1 3.2 1.8 0.3 0.1 
Crystal Meth 0.2 * - 0.2 - - 
Cannabis 8.3 4.7 17.1 6.2 1.5 0.1 
CLASS C 2.4 1.1 3.6 1.4 0.3 0.2 
Anabolic Steroids 0.6 0.1 0.2 0.1 - - 
Ketamine 1.0 0.4 1.8 0.4 - * 
Tranquilisers 1.3 0.8 2.4 1.0 0.3 0.2 
NOT CLASSIFIED 
      Glues/solvents/gas/aerosols 0.2 0.1 - 0.4 - - 
Poppers 1.2 0.5 2.1 0.7 0.2 - 
NEW DRUGS 1.4 0.8 3.3 0.8 0.2 0.1 
Mephedrone 1.1 0.6 3.1 0.4 0.1 0.1 
BZP, GBL, Khat, SC or SD 0.4 0.2 0.3 0.4 0.1 0.1 
ANY STIMULANTS 6.6 3.9 13.8 5.5 1.1 0.1 
ANY OPIATES 1.2 0.4 0.8 1.0 0.1 * 
ANY PSYCHEDELICS 1.9 0.7 3.7 0.7 - * 
ANY DOWNERS / 
TRANQUILISERS 1.3 0.8 2.4 1.0 0.3 0.2 
ANY DRUGS 10.8 6.4 21.0 9.3 2.1 0.5 
ANY DRUGS EXC. NEW DRUGS 10.6 6.2 20.3 9.1 2.0 0.4 
Base: 10,220 5,800 480 1,800 1,560 1,980 
 
Variable Name: QOF2 
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Table A1.17 Polydrug and drug and alcohol use in the last 12 months among 
adults over 16 using illicit drugs in the last 12 months 
SCJS 2012/13 
Percentage of 
adults 16 and 
over who have: 
Ever taken different 
drugs together at 
the same time, if 
have taken more 
than one drug in the 
last 12 months  
Base 
more 
than 
one 
drug in 
last 12 
months 
Ever consumed 
alcohol at the same 
time as taking 
drugs, if have taken 
any drugs in the last 
12 months 
Base 
any 
drug in 
last 12 
months 
GENDER 
    Male 56.5 150 65.9 340 
Female 45.3 60 59.8 160 
VICTIM STATUS 
    Victim of crime 62.7 60 59.6 150 
Non-victim 50.6 150 66.2 350 
TENURE 
    Owner-occupier 50.3 60 72.8 170 
Social renter 65.4 90 53.8 190 
Private renter 38.2 50 65.0 120 
DEPRIVATION 
    15% most 
deprived # # 54.2 100 
Rest of Scotland 52.6 160 66.9 390 
ALL ADULTS 54.1 210 64.2 490 
 
Variable name: 
Q12MMIX 
 
Variable name: 
Q12MALC 
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ANNEX 2: SELF-COMPLETION METHODOLOGY 
This section provides more detail about the self-completion section of the 
questionnaire for the SCJS 2012/13 specifically for the questions covering illicit drug 
use. Details are also included about the self-completion interview, the weighting 
used on the data and the classifications of illicit drugs used in this report. 
Further information about the design of the SCJS is contained in Annex 2 of 2012/13 
Scottish Crime and Justice Survey: Main Findings report and in the accompanying 
Technical Report. 
A.2.1 The self-completion interview 
Fieldwork for the SCJS 2012/13 was continuous and took place between the 1st of 
April 2012 and the 31st of March 2013. 
Interviews were conducted face-to-face in-home and were administered by specially 
trained professional interviewers working for TNS BMRB using Computer Assisted 
Personal Interviewing (CAPI). For the self-completion interview, the questionnaire 
was completed by respondents on the interviewer‟s tablet PC (Computer Assisted 
Self-completion Interviewing – CASI). This ensures confidentiality when answering 
sensitive questions or those on illicit behaviour. The respondent was asked to follow 
the instructions on the screen of the tablet PC and enter their answers using a 
special pen to tap the touch screen appropriately. 
85% of respondents completed the self-completion section and of those 66% 
entered their answers directly into the tablet PC themselves and 19% asked the 
interviewer to administer the questionnaire for them.  
The average questionnaire length of the self-completion section was nine minutes 
and 41 seconds. 
A.2.2 Questionnaire Content 
The SCJS 2012/13 consists of three elements: 
 The main questionnaire consists of a set of core modules asked of the whole 
sample, including demographics; and a set of full and quarter-sample 
modules, containing questions on a variety of topics; 
 A victim form questionnaire which collects details about the separate 
incidents a respondent may have experienced during the reference period. 
This victim form can be repeated up to five times. The number of victim forms 
completed depends on the number and nature of incidents respondents 
experienced; 
 A self-completion questionnaire covering sensitive issues, including illicit 
drug use. All respondents were asked to complete a self-completion 
questionnaire, but had the option to refuse this due to the sensitive nature of 
the questions. 
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Respondents to the self-completion questionnaire on illicit drug use were first asked 
whether they had used any of the 17 illicit drugs/drug groups ever and also whether 
they had taken the fictitious drug semeron. Those respondents who have taken 
drugs in the past are then asked if they have taken them in the last 12 months and, 
for those who have, whether they have taken them in the last month. 
A series of follow-up questions are asked for the different groups, including: 
 For those ever using, which drug was the first ever taken; at what age they 
first took drugs, and what methods of drug taking they have ever tried;  
 For those using in the last 12 months, whether they have mixed these drugs, 
consumed alcohol at the same time as taking them, how they would describe 
their usage, and whether they have taken anything else in the last 12 months 
which they thought was a drug;  
 For those taking drugs in the last month, which one they have taken most 
often, how difficult it is to get hold of, where they obtained it the last time they 
took it, and, in the last month, how many times they have used it, whether 
they felt dependant on it, tried to cut down and whether they managed to.  
 Those who have ever used cannabis, cocaine, ecstasy, tranquiliser or 
amphetamine, but not used any drugs in the last 12 months are asked at what 
age they last took it, whether they have ever felt dependant on any of the 
drugs they have ever taken, and which ones, as well as, for those who have 
felt dependant, whether they received any help in stopping taking them and 
from whom. 
The questions about which drugs respondents have taken are asked in a loop (i.e. 
„have you ever taken <drug name>?) rather than by selection from a single list of 
drugs.  
A.2.3 Disclosure of sensitive information 
Given the sensitive nature of the questions, especially as the majority of the 
questions on illicit drug use were on offending behaviours rather than victimisation 
(as opposed to the remainder of the self-completion questionnaire and the main 
questionnaire), a separate „Don‟t wish to answer‟ button was provided at the top of 
the screen at every question in the self-completion section of the questionnaire. 
At the start of the questions on illicit drug use, respondents were reminded that the 
answers they gave were completely confidential, reminded not to answer the 
questions including any drugs for which they had a prescription, and asked to 
answer the questions honestly: 
“The following questions ask whether or not you have ever used drugs. Please 
answer them honestly. The answers you give are completely confidential. Please 
DO NOT tell us about drugs you have been given on prescription.” 
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A.2.4 Drugs Classification 
The classifications of drugs used in this report are detailed in section 1.5. However, 
there are two points of clarification which readers should note: 
1. Amphetamines can be classified as either Class A (when prepared for injection) or 
Class B (in powdered form). Since questions used in the SCJS do not distinguish 
between the forms of the drug taken for the purposes of analysis, the report 
assumes that all amphetamine use is of the Class B type. This is consistent with the 
approach adopted by previous surveys, including the 2008/09 and 2009/10 SCJS. 
2. The category “not classified” indicates that possession of these substances 
(poppers and glues, solvents, gas or aerosols) is not illegal but it is an offence to 
supply these substances if it is likely that the product is intended for abuse. 
A.2.5 Non-response to the self-completion section 
10,235 (85%) respondents to the main survey answered the self-completion 
questionnaire. Table A2.1 compares the profile of respondents who answered the 
self-completion section of the questionnaire (including those who did so where the 
interviewer administered the questionnaire) and those who did not answer it: 
 The table shows that there was no difference between men and women in 
conversion from the main interview to self-completion. However, the 
proportion of those completing the self-completion section decreased as the 
age group of the respondent increased, falling from 93.2% for 16 to 19 year 
olds to 62.8% for those aged 85 or older. 
The most common reason for non-completion of the self-completion questionnaire 
given by respondents was running out of time (mentioned by 54%). Only 3.5% of 
respondents refused to complete the self-completion questionnaire because of 
worries about confidentiality.  
Comparing the profile of respondents who completed the self-completion section in 
the SCJS 2012/13 (85%) to the previous two sweeps of the SCJS in 2010/11 (85%) 
and in 2009/10 (84%) shows that the response rate has remained very level. 
However, the response rate to the SCJS 2008/09 self-completion questionnaire was 
markedly lower at 69%.  There is an ongoing trend evident in the SCJS 2012/13 and 
from the previous three sweeps of the SCJS where equal percentages of males and 
females completed the self-completion section and the percentage of respondents 
who answered the self-completion questionnaire decreased as age increased. 
All data from the self-completion section has been weighted in order that the sample 
is representative of the population (see A.2.7).  
 
 
 
  
 
78 
 
Table A.2.1: Proportion of respondents completing self-completion section by 
age and gender    
SCJS 2012/13 
% of respondents 
participating in self-
completion section 
Male Female Overall 
16 to 19 93.5 92.9 93.2 
20 to 24 85.3 87.6 86.6 
25 to 29 87.6 85.9 86.6 
30 to 34 87.5 87.3 87.4 
35 to 39 87.5 87.3 87.4 
40 to 44 84.2 86.1 85.3 
45 to 49 83.9 89.5 87.1 
50 to 54 86.4 89.7 88.2 
55 to 59 90.1 86.5 88.1 
60 to 64 81.6 87.4 84.8 
65 to 69 86.6 87.8 87.2 
70 to 74 83.7 82.4 83.0 
75 to 79 81.1 74.9 77.5 
80 to 84 78.0 69.8 72.8 
85 plus 65.5 61.4 62.8 
Overall 85.0 85.0 85.0 
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A.2.6 Sample Profile 
Table A2.2 provides the profile of the achieved sample of the self-completion section 
of the SCJS 2012/13 before weighting was applied and the weighted sample profile. 
In the SCJS 2012/13, men were underrepresented in the sample particularly men 
aged 16-24 and 25-44. Women aged 16-24 were under-represented in the sample 
but women in the remaining three age groups were over-represented. Weighting was 
applied to ensure that the sample was representative of the population. 
Table A2.2: Unweighted and weighted sample profiles by age and gender   
SCJS 2012/13   
Percentage 
Unweighted 
Sample
38
 
Weighted 
sample
39
 
Men     
16-24 3.8 7.3 
25-44 12.8 15.8 
45-59 11.5 12.3 
60+ 15.2 12.5 
Base 4,420 2,078,490 
Women     
16-24 4.6 7.1 
25-44 17.6 16.2 
45-59 15.2 13.2 
60+ 19.3 15.7 
Base 5,800 2,258,730 
All men 43.2 47.9 
All women 56.8 52.1 
Base (all respondents) 10,240 4,337,220 
 
Base: All respondents to self-completion questionnaire (10,240) 
 
 
  
                                               
38 The unweighted sample includes eleven respondents who said they had taken semeron at some 
point in their lives and who were subsequently excluded from the data for the drugs questions 
39 For the SCJS 2012/13, the population totals used were the National Records of Scotland‟s (NRS) 
“Mid-2011 Population Estimates Scotland”.  
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A.2.7 Weighting 
The data from the SCJS 2012/13 was weighted by the Scottish Government in order 
to correct for unequal probabilities of selection and variations in response rates from 
different groups. Calibration weighting was used to derive weighted survey totals 
which match known population totals.40 Separate weights were required for the self-
completion section since not all respondents to the main section of the survey SCJS 
completed the self-completion section. The individual weight was applied to all of the 
questions included in this report as they all related to the experiences and opinions 
of individuals. 
All data in this report is weighted data with the original base size provided in figure 
headings.  
 
  
                                               
40 The SCJS 2012/13 Technical Report provides more information on the weighting process.  
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